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EXAMINING DEPRESSIVE SYMPTOMS OVER TIME IN WOMEN WITH CORONARY HEART DISEASE 
Sydney A. Buckland, PhD 
University of Nebraska Medical Center, 2019 
Supervisor: Bunny Pozehl, APRN, PhD. 
 
Coronary heart disease (CHD) is the number one killer of women in the US. Women also 
experience roughly twice as much depression as men, and depression in CHD is associated with 
increased morbidity and mortality. Despite these facts, women continue to be under-
represented in CHD research, and results by gender are not routinely reported. 
Screening for depression in this population is problematic due to inconsistent inclusion of 
somatic symptoms on screening instruments and disagreement about appropriate cutoff scores. 
This body of work clarifies the concept of depression in women with CHD, presents a 
systematic review of the longitudinal literature on depressive symptoms in women with CHD 
examined by instrument, and presents results of a 3-month feasibility study examining women’s 
depressive symptoms. The purpose of the study was to evaluate participant enrollment, data 
collection, preliminary quantitative trends, and qualitative surveys for qualitative data 
collection. 
Participant recruitment by individuals other than the P.I. was generally poor and attrition 
was problematic (16.7 – 28%). Prevalence of mean depression screening scores ≥ cutoff values 
averaged 30% at baseline, 26% at month 2, and 25% at month 3. Trends in symptom severity 
over the course of the study reflected trends in somatic symptoms and distress but not cognitive 
symptoms. Current depression was strongly correlated with fatigue and sleep as well as younger 





less strongly correlated with a history of depression and cardiac rehabilitation attendance. No 
correlation was found between current depression and employment status. Qualitative survey 
uptake was poor and the original survey was too restrictive, requiring modification. 
This dissertation clarifies our understanding of the concept of depression in women with 
CHD and summarizes the longitudinal descriptive literature on depression in women with CHD. 
The dissertation study enhances our understanding of depressive symptoms experienced in this 
population, gives some important preliminary data on use of the PROMIS Depression 8b 
instrument in this population, highlights the importance of screening for depressive symptoms 
in this population, and emphasizes the ongoing need for CHD studies which examine and report 
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Chapter I. Introduction 
 
Numerous scientific articles have been published on the connection between mental health 
and coronary heart disease (CHD), particularly depression. It is now well-established that the 
development of depression following a cardiac event increases the risk of both morbidity and 
mortality (Barth, Schumacher, & Herrmann-Lingen, 2004; Carney et al., 2009). In 2014, the 
American Heart Association recommended that depression be elevated to the status of risk 
factor for poor prognosis following acute coronary syndrome (Lichtman, 2014). Depression is 
also now recognized as being a risk factor for the development of CHD (O’Neil et al., 2016), with 
ongoing work exploring this connection from multiple perspectives, including possible genetic 
linkages. 
It is widely recognized that women are affected by depression at a rate of roughly 2:1 
compared to men, starting at menarche and continuing until post-menopause. This 2:1 ratio is 
true in both the general population as well as the CHD population. But as with other previous 
heart disease research, examination of depression data by gender has not been routinely 
undertaken and women continue to be under-represented in cardiac research.  Studies which 
have examined women separately have found that women and men do not always have the 
same CHD experience. This includes symptoms of acute coronary syndrome, acute myocardial 
infarction, and more recently there is evidence that women experience more microvascular 
disease and stress-induced ischemia than men (Bairey Merz et al., 2006; Vaccarino et al., 2016). 
The continued lack of women in CHD research, coupled with lack of data analysis by gender in 
much of the published literature, has meant that even though women experience twice as much 
depression as men, their depressive symptom experiences remain largely invisible.  





Research has demonstrated that women with CHD tend to experience more depressive 
symptoms than men, both initially and over time (Buckland, Pozehl, & Yates, 2019), and women 
tend to experience more “somatic” (physical) symptoms than men (Frazier et al., 2012; Grace, 
Yee, Reid, & Stewart, 2014; Roest, Wardenaar, & de Jonge, 2016).  However, the instruments 
used to screen for depressive symptoms vary widely. While DSM-5, the Diagnostic and Statistical 
Manual of Mental Disorders, fifth edition, defines the criteria for diagnosing depression and all 
its subtypes, these screening instruments do not necessarily follow DSM criteria. Some, in fact, 
do not include somatic symptoms at all. This, in effect, creates different operational definitions 
of depression. This poses a significant challenge when using these instruments to screen for 
depression in women in research studies as well as clinical settings. 
Because of the lack of representation of women in heart disease research, and to highlight 
the problems posed by the widely-varying depression screening instruments, the concept of 
depression in women with CHD needs to be clarified. Chapter 2 of this dissertation looks at 
depression in women with CHD as a concept, following the steps of concept analysis as 
presented by Walker and Avant (Walker & Avant, 2011). Chapter 2, “Clarifying the concept of 
depression in women with coronary heart disease,” was published ahead of print on March 7, 
2019 in Advances in Nursing Science. The manuscript was co-authored by Dr. Bunny Pozehl, 
current dissertation committee chair, and Dr. Bernice Yates, previous committee chair. 
Depression in Women with CHD: State of the Science 
 Because depressive symptoms can and do last beyond the acute cardiac event and are 
associated with worse outcomes, an understanding of what happens with depressive symptoms 
in this population over time is important. Therefore, an examination of the longitudinal CHD 
literature which included women, assessed depressive symptoms at more than one timepoint, 





the results of this systematic literature review, which also compared findings by depressive 
screening instrument and, when possible, used prevalence data to compare findings since the 
results of different screening instruments are not easily compared. Chapter 3, “Depressive 
symptoms in women with coronary heart disease: a systematic review of the longitudinal 
literature,” was submitted as a manuscript to the Journal of Cardiovascular Nursing. It was 
accepted for prior-to-print publication as an open access article and appears in the 
January/February 2019 issue. The manuscript was co-authored by Dr. Bunny Pozehl, current 
dissertation committee chair, and Dr Bernice Yates, previous committee chair. 
Results of a Mixed Methods Longitudinal Feasibility Study Examining Depressive Symptoms in 
Women with Coronary Heart Disease 
Given the problematic nature of using various different depressive screening 
instruments in the CHD population, the lack of longitudinal data which examines women 
specifically, as well as the difficulty in ascertaining the true nature of somatic symptoms which 
overlap both CHD and depression, this author chose to explore the feasibility of conducting a 
study to examine each of these components in women who had recently experienced a cardiac 
event (acute coronary syndrome, myocardial infarction, percutaneous coronary intervention, or 
coronary artery bypass graft). The research was guided by Lenz’ middle-range Theory of 
Unpleasant Symptoms and was adapted to a conceptual framework of depressive symptoms in 
women with coronary heart disease. 
Specific Aims 
The specific aims of this descriptive longitudinal mixed methods feasibility study were 






1. Evaluate participant enrollment, including recruitment strategies and efficiency, attrition at 
each study timepoint, and enrollment and retention problems and solutions. 
2. Evaluate data collection at each of the data collection time points of baseline, month 2, and 
month 3, examining the use of REDCap vs paper, instrument reliability, the time required to 
complete instruments, and the amount of missing data. 
3. Evaluate data for preliminary trends in the following: 
a. the prevalence of women who meet the cut-point criteria for elevated depressive 
symptoms following a cardiac event at baseline, 2 months and 3 months post 
study enrollment as measured by 3 commonly-used tools to measure depressive 
symptoms and compare them to prevalence rates of elevated depressive 
symptoms found in previous literature. 
b. changes over time (baseline through month 3) in women's depressive symptom 
dimensions (severity, quality, symptom distress). 
c. the influence of CHD and depression on sleep, fatigue, and gastrointestinal 
symptoms (loss of appetite, taste, and nausea) post cardiac event at baseline, 2, 
and 3 months after study enrollment to estimate this effect size. 
d. the influence of age, diabetes, employment status, attendance at cardiac 
rehabilitation, a history of depression and/or anxiety, and concurrent acute 
coronary syndrome (ACS) symptoms on depressive symptoms at baseline, 2 
months, and 3 months after study enrollment in women post cardiac event. 
Qualitative 
4. Explore the acceptance and uptake of a qualitative survey as a qualitative data collection 
method with a sub-sample of 10-15 women who agree to participate at baseline, 2, and 3 





a. Do the qualitative survey entries provide the type of data sought using the semi-
structured survey provided? 
b. How many women indicated they would complete qualitative surveys vs how 
many women actually completed these surveys at all 3 timepoints? 
c. Describe how the qualitative data concurred with or differed from the 
quantitative depression screening instrument scores? 
A more detailed discussion of the study and its aims, as well as the study’s results and 
conclusions will be presented in Chapter 4. 
Significance and Impact 
 Heart disease is the leading cause of death among American women – 22.3% of all female 
deaths in 2015 (https://www.cdc.gov/women/lcod/2015/race-ethnicity/index.htm). Depression 
is one of the leading causes of disability in the US, affecting roughly 12 million women in the US 
each year (Mental Health America, 2018), with women ages 40-59 being most affected (CDC, 
2018). The cost of heart disease and depression combined is enormous - an estimated $410 
billion per year in the US 
(https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_disease.htm; Workplace 
Mental Health, 2018).  Women with CHD are more frequently affected by depression than men 
but remain under-represented and understudied. 
The cost of underdiagnosed women with CHD who also experience depression – in terms of 
cost, lost productivity, and morbidity and mortality - is not trivial. We cannot afford to miss 
women with CHD’s symptoms of depression. The concept analysis presented in this dissertation 
identifies the defining attributes of depression in women with CHD so that those assessing this 





ensuring that women with CHD and depressive symptoms are correctly identified since we know 
that those who have CHD and comorbid depression have poorer outcomes. 
We also need a better understanding of what happens to women’s symptoms over time 
so that we are able to identify those who are at risk of developing significant depressive 
symptoms after their initial cardiac event or are at risk of having non-remitting symptoms. This 
investigation provides a preliminary understanding of the relationship between symptom 
dimensions as defined by Lenz - timing (here, changes over time), severity, quality (somatic vs 
cognitive) and distress – as well as the relationship between depressive symptoms, specific 
influencing factors, and somatic symptoms that overlap with CHD in order to help us to identify 
these women. 
With the new knowledge from these three manuscripts, more thorough assessment and 
appropriate interventions for women may be developed, leading to less depression burden, 
better outcomes, and ultimately less cost to the individual, community, and health care system. 
Summary 
In summary, the purpose of this dissertation is to explore depressive symptoms and 
their dimensions in women with CHD over time, looking carefully at the instruments used to 
assess depressive symptoms, the changes in prevalence of depression and its dimensions (as 
define by Lenz) over time, and the somatic symptoms common to both CHD and depression. 
This dissertation has been prepared following the 3-manuscript format as approved by 
the advisory committee. As noted previously, Chapter 2 has been published in the Journal of 
Cardiovascular Nursing, and Chapter 3 has been published ahead of print in Advances in Nursing 
Science. Chapter 4 contains the manuscript of the dissertation research study results. Finally, 
Chapter 5 contains an in-depth discussion of the conclusions of the study as well as implications 
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Chapter II. Manuscript 1 
Clarifying the concept of depression in women with coronary heart disease 
 




Coronary heart disease (CHD) is the leading killer of women in the US, causing about 1 in 
every 4 female deaths. And though heart disease mortality has declined significantly since its 
peak in the 1950s, it has declined less in women. In the mid-1990s, the scientific community 
began to explore the effects of depression on those with coronary heart disease. Approximately 
12 million women in the US are diagnosed with depression every year, and 1 in every 8 women 
will experience clinical depression in her lifetime. Research suggests that women experience 
depression at a rate of 2:1 compared to men among those with CHD as well as in the general 
population (Frazier et al., 2012). 
Depression has significant health ramifications in the CHD population. In 2014, the 
American Heart Association published a scientific statement elevating depression to the status 
of risk factor for poor prognosis among patients with acute coronary syndrome (Lichtman et al., 
2014). There is strong evidence for increased negative outcomes among those who develop 
depressive symptoms following a cardiac event, including increased morbidity and mortality 
(Lichtman et al., 2014). 
Evidence from work on acute coronary syndrome and acute myocardial infarction has 
demonstrated that women and men do not necessarily have the same CHD experiences. In fact, 
recent work has demonstrated that women experience more microvascular disease and stress-
induced ischemia than men (Bairey Merz et al., 2006; Vaccarino et al., 2016). However, women 





with lack of data analysis by gender in much of the published literature, has meant that even 
though women experience twice as much depression as men, their depressive symptom 
experiences remain largely invisible. 
While women’s depressive symptoms in this population have been explored, our review 
of the literature suggests that limited research has been done to understand and clarify the 
conceptual meaning of depression in women with CHD. From this review it appears that the 
conceptualization of depression in women with CHD is widely variable, and that this variability 
arises from the way the concept of depression is operationalized – i.e. the instruments used to 
measure the concept. The literature search conducted for this paper yielded 16 different 
instruments used to operationalize depression – from a 2-question screening instrument to the 
gold standard Composite International Diagnostic Interview (see Table 1).  Because different 
instruments ask different questions and not all instruments include questions about certain 
symptoms of depression (such has somatic symptoms), the actual concept of depression in 
women with CHD may not be captured by the instrument being used to measure the concept.  
Therefore, research on women with CHD and comorbid depression would benefit by a concept 
analysis of depression in women with CHD. 
Concept analysis, according to Walker and Avant (2011), is a “process of examining the 
basic elements of a concept… result[ing] in a precise operational definition that by its very 
nature increases the validity of the construct” (p. 158). Concept analysis can be used for various 
purposes, including refining ambiguity of a concept in a theory, clarification of an overused or 









The aim of this concept analysis of depression associated with a diagnosis of coronary 
heart disease in women is concept clarification. Concept analysis for the purpose of concept 
clarification is appropriate when a concept has a large body of literature defining and describing 
it, including quantitative instruments for measuring the concept, but the concept is measured 
using different variables and is applied inconsistently in the research (Morse, Hupcey, Mitcham, 
& Lenz, 1996). Clarifying the concept of depression in women with coronary heart disease is 
necessary for a better understanding of women’s experiences so that accurate diagnoses can 
lead to more timely and appropriate interventions. 
Design and Methods 
This paper is organized according to Walker and Avant’s (2011) eight-step approach to 
concept analysis: 1) selecting a concept; 2) determining the aim or purpose of the analysis; 3) 
identifying all uses of the concept; 4) determining the concept’s defining attributes; 5) 
identifying a model case; 6) identifying additional cases (borderline and contrary cases); 7) 
identifying antecedents and consequences, and; 8) defining empirical referents.  
To begin this concept analysis, the basic concept of depression was identified, aims 
determined, and its use in both medical and non-medical settings explored. A literature search 
from 1990 to August 15, 2018 of English language articles was then performed to explore the 
concept of depression specifically in women with CHD. A PUBMED search utilizing the terms 
coronary heart disease, depression, and sex factors or sex differences, with the filters female, 
human, and English language yielded 100 articles. Because this concept analysis focuses 
specifically on coronary heart disease (rather than the larger concept of cardiovascular disease), 
articles related to heart failure, stroke, and peripheral vascular disease were removed. Articles 





these exclusions, 40 articles remained. These articles were used to define the concept’s critical 
attributes, antecedents, and consequences; cases were constructed using the concept; and 
empirical referents identified. Finally, the use of this concept in future research and clinical 
practice is discussed.  
Uses of the Concept 
The word “depression” has several different meanings and uses. Apart from its use in 
common parlance, usually to indicate a low mood, it is also used in mathematics, astronomy, 
meteorology, economics, and healthcare. Merriam-Webster’s online dictionary lists several 
definitions: the angular distance of a celestial object below the horizon; the size of an angle of 
depression; a pressing down, such as a depression of the tab key on a keyboard; a state of 
feeling sad; a place or part that is lower than the surrounding area; a low, as in a tropical 
depression, or; a long period of low general economic activity marked especially by rising levels 
of unemployment. 
The National Institutes of Mental Health (NIMH) gives this definition of depression: 
“Depression (major depressive disorder or clinical depression) is a common but serious mood 
disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities, 
such as sleeping, eating, or working. To be diagnosed with depression, the symptoms must be 
present for at least two weeks”(Nation Institute of Mental Health, 2018). 
Hare and Davis (1996), who created the Cardiac Depression Scale to assess for 
depression in the cardiac population, used the DSM-4 (American Psychiatric Association, 1994) 
criteria for “adjustment disorder with depressive symptoms” as their definition of depression. 
According to DSM-4, “adjustment disorder with depressive symptoms” is defined as: “the 
development of emotional or behavioral symptoms in response to an identifiable stressor(s) 





would typically be expected or significant impairment in social or work functioning. These 
symptoms do not exceed 6 months in duration once the stressor is over. 
The Diagnostic and Statistical Manual of Mental Disorders (DSM), published by the 
American Psychiatric Association (APA), provides the medical diagnostic criteria for depression 
as a mental health disorder. DSM-5, the most recent edition of the manual, lists eight different 
diagnoses that fall under the category of depressive disorders: disruptive mood dysregulation 
disorder, major depressive disorder, persistent depressive disorder (dysthymia), premenstrual 
dysphoric disorder, substance/medication-induced depressive disorder, depressive disorder due 
to another medical condition, other specified depressive disorder, and unspecified depressive 
disorder. Though there are significantly different components to each of these eight diagnoses, 
they all share common core features: sadness, emptiness, or irritable mood, accompanied by 
somatic and cognitive changes that significantly impact an individual’s ability to function. Per 
DSM-5 criteria, a diagnosis of major depressive disorder (MDD - the diagnosis most researchers 
refer to when talking about depression in the CHD population) requires either depressed mood 
or loss of interest or pleasure (anhedonia) plus 3-4 of the other 7 core symptoms (for a total of 
at least 5 core symptoms) during a consecutive 2-week period. So-called “minor depression” (or 
“depressive episode with insufficient symptoms”, defined under “other specified depressive 
disorders” in DSM-5) requires only a depressed affect and 1 of the 8 other core symptoms of 
MDD, with the same duration and distress or functional impairment as MDD to meet criteria. 
More recently, Ormel and de Jonge (2011) developed an integrative model of 
depression in the setting of CHD. Their model proposes two subtypes of depression: 1) 
cognitive-affective (also called “typical”), characterized by depressed mood, anhedonia, 
negative feelings such as self-dislike & sense of failure, guilt, interpersonal sensitivity, and future 





psychomotor agitation/retardation, sleep problems, aches and pains, appetite disturbance, 
weight disturbance, and work difficulty. 
These authors are interested specifically in depression in women following a diagnosis 
of CHD (as opposed to depression as a precursor to its development). In the majority of studies 
looking at depression in individuals with CHD, the authors do not provide a conceptual definition 
of depression. Rather, depression is given an operational definition via the instrument used to 
assess it. Confusingly, this leads to numerous different operational definitions. 
Operational definitions. 
The gold standard for evaluating patients for depression is the structured clinical 
interview (American Psychiatric Association, 2018). However, such interviews are usually rather 
lengthy (45 – 120 minutes)   for research participants. Of the 40 articles reviewed for this paper, 
only 2 used an interview to assess for depression. Therefore, most researchers rely on 
instruments that screen for depression rather than completing a diagnostic interview, and cutoff 
scores become a proxy for clinically significant depressive symptom burden. This makes these 
screening instruments of paramount importance - the symptoms included on the screening 
instrument become the operational definition of depression. 
The instruments used to assess depressive symptoms in the CHD population can be 
grouped into three categories based on the symptoms included/excluded and the origins of 
their development: 1) instruments based on DSM criteria for depression that include somatic 
symptoms, 2) instruments that do not include somatic symptoms, and 3) instruments based on 
other criteria. Because of the multiple instruments used, three commonly used instruments will 
be discussed as exemplars of the three categories. Table 1 lists all depression assessment 






Table II-1: Depression screening instruments found in the literature search 
DSM* + somatic symptoms No somatic symptoms Non-Major Depressive 
Disorder/Non-DSM* criteria 
Beck Depression Inventory Hospital Anxiety & 
Depression Scale 
Zung Self-Rating Depression Scale 
Beck Depression Inventory-II Patient Health 
Questionnaire 2-item 
Geriatric depression scale 




Hamilton Depression scale*** 
Center for Epidemiologic Studies 
Depression scale 
PROMIS Depression** Gotland scale 
Center for Epidemiologic Studies 
Depression scale 8-item 
 Global Health Questionnaire 60-
item 
  EuroQuol-5D 
  Symptom CheckList 90 
*Diagnostic & Statistical Manual 
**Instrument not found in the literature search, but increasingly important in research 
***Administered by a clinician, but not a diagnostic interview 
 
Instruments based on DSM criteria that include somatic symptoms. 
The first category of depression scales is those that were created based on the accepted 
criteria for major depressive disorder (MDD) at the time of their creation and include both 
cognitive and somatic symptoms. The best example of this is the Beck Depression Inventory 
(BDI), originally published in 1961. Beck and his colleagues created a depression measurement 
instrument by observing attitudes and symptoms displayed by depressed psychiatric inpatients 
and outpatients at two hospitals in Philadelphia, consulting the newly-published Diagnostic and 
Statistical Manual of Mental Disorders-I (DSM-I), and finally consolidating these observations 
into a 21-item questionnaire (A. T. Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). The BDI-II, 
an update to the original scale, was published in 1996 in response to the publications of DSM-3-
R and DSM-4 to make it more consistent with the current diagnostic criteria. Other scales found 
in this review that are based on DSM criteria and include both cognitive and somatic symptoms 
include the Center for Epidemiologic Studies Depression scale (CES-D) and its shorter version, 





Instruments that do not include somatic symptoms. 
The second category of scales measuring depression do not include somatic symptoms. 
These were often developed to avoid measuring somatic symptoms that may have reflected 
physical rather than mental illness. The hallmark example of this category of scales is the 
Hospital Anxiety and Depression Scale (HADS). The HADS, developed by Zigmond and Snaith 
from research conducted in general medical outpatient clinics and originally published in 1983, 
focused on anhedonia as the central concept of depression. Zigmond and Snaith felt there was 
no easy way to distinguish between physical symptoms rooted in a physical ailment and physical 
symptoms reflective of a mental illness. They wanted an easy way to detect mental illness in 
order to avoid a lengthy physical work-up. So Zigmond and Snaith created an instrument where 
“…symptoms which might equally arise from somatic [physical] as from mental disease” were 
excluded (Zigmond & Snaith, 1983). This concern about inclusion of somatic symptoms (such as 
fatigue, changes in appetite, or sleep disturbance) measuring a physical rather than mental 
illness, and subsequent overestimation of depression (Zigmond & Snaith, 1983) is echoed in the 
more recently developed NIH-sponsored PROMIS depression instruments, which also do not 
include any somatic depressive symptoms. Other assessment instruments, such as the PHQ-2 
and the General Health Questionnaire 30-item, are shortened version of longer instruments 
which have removed the somatic items. 
Instruments based on other criteria. 
The last category of depression scales is based on some criteria other than DSM MDD 
criteria. The exemplar for this category is the Zung Self-Rating Depression Scale. Though DSM-I 
had been published in 1952 it was not widely used until DSM-3 was published in 1980, 
representing “a veritable paradigm shift in psychiatry” (Kawa & Giordano, 2012). The Zung scale 





broad domains were identified - pervasive affect, physiological equivalents, and psychological 
equivalents - and the most commonly-found characteristics in the factor analyses were fitted 
into these domains and comprised the symptoms assessed by the scale. Subsequently, records 
of interviews with patients were reviewed and statements which seemed most representative 
of a particular symptom were chosen to create the scale. The final scale was a 20-item 
questionnaire. Other examples of instruments in this category include the Geriatric Depression 
Scale (based on the Research Diagnostic Criteria developed by the National Institutes of Mental 
Health Psychobiology of Depression Collaborative Study, published in 1978), Gotland scale of 
male depression (developed in 2002 with alcohol-dependent men, with questions about 
irritability, aggression, and alcohol use) and the General Health Questionnaire 60-item 
(developed in the 1970s for identifying minor psychiatric disorders in the general population), 
among others. 
The importance of “minor” depressive symptoms. 
Strik and colleagues (2001) argue that the use of self-report depression scales to screen 
for depression in clinical patients, such as those described above, are only justified if they 
demonstrate high concurrent validity with DSM criteria for major and minor depression (italics 
added). In a study examining the sensitivity and specificity of three frequently-used 
questionnaires for depression in myocardial infarction (MI) patients, Strik et al. (2001) noted 
that optimum cutoff scores (the score which combines maximal sensitivity with optimal 
specificity on a receiver operating characteristics [ROC] curve) for MI patients are below the 
generally accepted cutoff scores (which were determined using the population in which the 
instrument was originally designed and tested). The generally accepted cutoff scores would 
capture MDD but miss those with minor depression. Doering et al.’s (2006) study demonstrates 





met criteria for minor depression. Additionally, if women experience a preponderance of 
somatic symptoms which are not captured on the depression scale being used, they will be 
under-diagnosed or missed altogether. Ketterer and colleagues argued that there is a problem 
with the DSM-4 threshold in patients with CHD in that it is too high and likely to overlook 
patients with depression. That is, "…MDD criteria appear to exclude patients who are at risk for 
adverse outcomes from CHD.  . . .  Furthermore, many other investigators have found 'minor' 
depression to be predictive of CHD morbidity and mortality”(Ketterer et al., 2006, p. 53). 
Defining Attributes 
Walker and Avant (2011) describe the defining attributes of a concept as “a cluster of 
attributes that are most frequently associated with the concept . . . [and] functions very much 
like the criteria for making differential diagnoses in medicine” (p. 162). Several authors have 
argued that individuals with heart disease, and women with CHD in particular, experience more 
“somatic” symptoms than “cognitive” symptoms (de Miranda Azevedo, Roest, Hoen, & de 
Jonge, 2014; Grace, Yee, Reid, & Stewart, 2014; Linke et al., 2009; Sanner, Frazier, & Udtha, 
2013). Furthermore, low levels of depressive symptoms (i.e., fewer symptoms than required to 
meet criteria for MDD) are not unusual in those with CHD and have also been associated with 
worse outcomes such as increased all-cause and cardiac mortality (Lichtman et al., 2014). 
Examining specific symptoms as attributes of this concept, several studies have 
supported a group of symptoms as being the most common in women with CHD. These 
symptoms include dysphoria/sadness; self-dislike; tiredness/fatigue; loss of energy; sleep 
disturbances; appetite disturbances; concentration difficulties; indecisiveness; crying; and loss of 
interest in sex (Doering et al., 2006; Frazier et al., 2012; Grace et al., 2014; Sanner et al., 2013). 
Some of these symptoms are considered dimensions of the cognitive aspect of depression 





considered dimensions of the somatic aspect of depression (tiredness/fatigue, appetite 
disturbance, loss of energy, sleep disturbance, and loss of interest in sex) (see Table 2). Frazier 
et al. (2012) found that women had significantly higher scores than men on the following items 
from Beck’s depression inventory: sadness, self-dislike, crying, indecisiveness, sleep disturbance, 
appetite disturbance, and loss of interest in sex. Similarly, Grace and colleagues (2014), in 
comparing men’s and women’s scores on the BDI-II and the Gotland Scale of Male Depression 
(GSMD), found that women scored significantly higher than men on indecisiveness (BDI-II), 
crying (BDI-II), tiredness (BDI-II), loss of energy (BDI-II), inexplicable tiredness (GMSD), sleep 
problems (GSMD), changes in sleep patterns (BDI-II), loss of interest in sex (BDI-II), 
concentration difficulty (BDI-II), and changes in appetite (BDI-II).    
In addition to women scoring higher on depressive symptoms overall compared to men 
in both studies, significantly more women in Frazier et al.’s (2012) study reported experiencing 
somatic symptoms (sleep disturbance, appetite disturbance, and/or fatigue) than men, and in 
Grace et al.’s (2014) study women scored significantly higher on the “psychomotor fatigue” 
factor (“i.e. somatic features”) than men (p. 948). 
The defining attributes delineated here must be present in any operationalized 
definition of depression in women with CHD. In other words, the screening instruments used in 
women with CHD must contain these attributes if we hope to adequately and accurately assess 
this population. 





Dysphoria/sadness Sleep disturbances 
Indecisiveness Appetite disturbances 
Self-dislike/poor self-esteem Loss of interest in sex 








According to Walker and Avant(2011), a model case is one “that demonstrates all the 
defining attributes of the concept” (p. 163); an exemplar. They may be found in the literature or 
created for the purposes of the concept analysis. The following is a model case for depression in 
women with CHD. 
Marilyn is a 53-year-old divorced female with a personal history of poorly-
controlled type-II diabetes, hypertension, anxiety, and obesity who suffered an ST-
elevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and 
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and 
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides 
with her. 
Marilyn has returned home from the hospital, but instead of feeling better she 
finds she is now always tired and has little to no energy. Though she knows she should 
be attending cardiac rehabilitation, she cannot bring herself to go. She is sleeping poorly 
and is unable to concentrate on the things she needs to get done. She has no appetite 
and forgets to eat. She has missed two weeks of work due to her heart attack, and 
though she typically enjoyed her job, is now ambivalent about returning to work. She 
often finds herself laying on her bed crying, wondering how she is supposed to “take 
better care of herself”, care for her mother, and go back to work when she cannot even 
get out of bed in the morning. She hates herself for not having managed her diabetes 
better, getting so fat and out of shape, and now having heart disease on top of 
everything else, and cannot imagine how she is ever going to manage. 
This model case is a clear example of depression in a woman following a CHD diagnosis. 
Additional Cases 
 Borderline case. 
 A borderline case will have some but not all of the defining attributes of the concept. 
Marilyn is a 53-year-old divorced female with a personal history of poorly-
controlled type-II diabetes, hypertension, anxiety, and obesity who suffered an ST-
elevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and 
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and 
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides 
with her. 
Marilyn has returned home from the hospital and remains fatigued with little 
energy. She knows attending cardiac rehabilitation is important and though she is tired 
she forces herself to attend anyway. She is less afraid of exercising than she was at first 





She has missed two weeks of work due to her heart attack, and though she 
typically enjoyed her job she is now ambivalent about returning. She is working hard at 
trying to do what she is supposed to be doing (like eating better, checking her blood 
sugars every morning, and remembering to take her medication every day) and take 
care of her mother as well. 
 Contrary Case. 
 A contrary case would not display the defining attributes of the concept. 
Marilyn is a 53-year-old divorced female with a personal history of poorly-
controlled type-II diabetes, hypertension, anxiety, and obesity who suffered an ST-
elevation MI 2 weeks ago. She was treated with an emergent heart catheterization, and 
two drug-eluting stents were placed at that time. Her father died of an MI at age 46, and 
her mother had a stroke at age 65. She is now a caregiver for her mother, who resides 
with her. 
Marilyn has returned home from the hospital and has started attending cardiac 
rehab. Though she still gets tired, she is feeling much better about how things are going 
now. She is sleeping well and her appetite is back. She has missed two weeks of work 
due to her heart attack and was initially apprehensive about returning, but now is 
feeling more confident and is looking forward to returning once her doctor says it’s OK. 
She has found that in focusing on taking better care of herself she has actually gotten 
her mother to engage in some healthier choices and increased activity as well, making 
these lifestyle changes easier to implement. 
Antecedents 
According to Walker and Avant (2011), antecedents of a concept “must occur or be in 
place prior to the occurrence of the concept” (p. 167). Two antecedents to the concept of 
depression in women with CHD are clear: (1) female gender and (2) a diagnosis of coronary 
heart disease. It has long been recognized that women are at increased risk for depression 
compared to men. Women experience depression at a rate of roughly 2:1, beginning at 
menarche and continuing until menopause. The role of fluctuating levels of estrogen has been 
hypothesized as explaining this difference, since women’s rates of depression begin to increase 
just as hormonal fluctuation begins and decline once these fluctuations cease (Albert, 2015). 
Women are also more vulnerable to depressive symptoms prior to menstruation, following 





Depression in the CHD population is even more common than in the general population. 
Those who have had an MI experience depression at a rate of 17%-27% (vs 10%-29% in the 
general population), and this rate is about twice as high in women with MI versus men 
(Lichtman et al., 2014). The literature around depression in CHD also suggests that the 
magnitude of the precipitating cardiac event or severity of the disease does not equate to the 
emotional response (Doyle, McGee, Conroy, & Delaney, 2011). In other words, a minor heart 
attack or only minor intervention does not mean a less dramatic emotional response. Likewise, a 
major heart attack requiring a sizeable surgical intervention does not mean a more significant, 
deeper depressive response. 
Several other possible antecedents for this concept of depression have also been 
described in the literature. These can be divided into two groups: physiological vulnerabilities, 
including genetics, younger age, presence of angina, and comorbid diabetes; and psychosocial 
vulnerabilities, including poor social support following a cardiac event, inability to return to work 
following the cardiac event, and comorbid anxiety (see Table 3). 
Physiological vulnerabilities. 
Several authors have explored genetic vulnerability to depression in those with CHD 
(Kendler, Gardner, Fiske, & Gatz, 2009; Liu et al., 2014; McCaffery et al., 2006). Though an 
emerging area of scientific inquiry, these studies are beginning to elucidate a genetic link 
between depression and CHD. McCaffery and colleagues (2006) cite several studies which 
suggest a possible common genetic “substrate” between CHD and depression and propose 
several candidate genes involving the inflammation and serotonin-mediated platelet 
aggregation pathway. Liu and colleagues (2014), in examining seven possible single nucleotide 
polymorphisms (SNPs) on the brain-derived neurotrophic factor (BDNF) gene, were able to 





A twin study performed from the Swedish twin registry done by Kendler and colleagues (2009) 
found a moderately strong genetic correlation between major depression and CHD, which is 
slightly higher in women than men (+0.67 vs +0.62, respectively). 
Several studies have indicated that younger women with CHD appear more vulnerable 
to developing depression than older women (Doering et al., 2006; Grace et al., 2005; Naqvi et 
al., 2007). This may be due to younger women underestimating their risk for a cardiac event 
(Doering et al., 2006), or greater difficulty in adjusting to the uncertainties of a future that now 
includes a chronic illness in conjunction to the usual stressors of work and family roles (Grace et 
al., 2005). Pre- and peri-menopausal women will also still be vulnerable to fluctuating levels of 
hormones, as mentioned previously. 
The presence of angina appears to be significantly associated with depression in those 
with CHD (Jespersen, Abildstrom, Hvelplund, & Prescott, 2013; Portillo, White, Baisden, & 
Dawson, 1995). Women, particularly American women, experience more angina than men 
(Hemingway et al., 2008). Those who experience angina consistently scored higher on 
depression assessment instruments than those who did not (Jespersen et al., 2013). Portillo et 
al.’s study (1995) in Mexican-American women showed that more women with angina 
experienced depression than women who did not have angina, and that this group also had 
significantly more problems with functional impairment (which may in turn exacerbate 
depressive symptoms). In Jespersen et al.’s (2013) study, angina was also significantly associated 
with anxiety. 
Comorbidity with diabetes has also been strongly connected to depression in women 
with CHD in several studies (Annunziato et al., 2015; Kronish et al., 2006; Murphy et al., 2008). 
Kronish et al. (2006), in their study of ACS patients, noted that women with CHD and comorbid 





than women without diabetes. Murphy et al.’s (2008) 12-month study of women after an acute 
cardiac supports Kronish’s earlier finding of a link between higher incidence of depression in 
women with comorbid diabetes. Annunzio et al.’s (2015) study found significantly elevated risk 
of depression as well as suicidality in individuals with CHD and comorbid diabetes. Annunzio et 
al. conclude that “it appears that having diabetes and CVD may be more concerning from a 
[mental health] perspective than an MI” (p. 1282).  
Psychosocial vulnerabilities. 
Several psychosocial vulnerabilities have been identified in the literature regarding 
women with CHD and depression. Poor social support as a risk factor for depression in women 
following a cardiac event has been explored in several studies (Barefoot et al., 2000; Compare et 
al., 2013b; ENRICHD, 2001). Barefoot et al.’s (2000) work examining the link between depression 
and social support found that those with CHD and poor social support exhibited higher levels of 
depression compared to those with good social support. Interestingly, social support seemed to 
be a bigger factor in depression among younger patients with CHD than older patients.  The 
ENRICHD study, a groundbreaking study in the research of CHD and depression, found that over 
1/3 (34%) of patients in the study experienced both depression and low perceived social 
support, and these were predominantly women (ENRICHD, 2001). Compare et al.’s (2013a) ten-
year literature review examining the relationship between social support and depression in CHD 
patients (including marital relationships and social relationships) concluded that low levels of 
social support is important risk factor for both development and worsening of depression.  
Contrary to early hypotheses regarding work stress in women with CHD, research has 
shown that women who are unable to return to gainful employment experience more 
depression than those who are able to return to work (Blom et al., 2007; Boudrez & De Backer, 





the association between work and depressive symptoms. They concluded that women who 
were working demonstrated lower levels of depressive symptoms than those who were not, 
regardless of age, educational status, or risk factors for CHD (including diabetes). Work also 
increased the degree of social support experienced by these women. Boudrez and DeBacker 
(2000) examined return to work in acute myocardial infarction or coronary artery bypass graft 
patients. They found that, after one year, those who had returned to work demonstrated more 
positive affect, less negative affect, and fewer somatic complaints.  
Anxiety has been shown to have significant co-occurrence with depression in both the 
general population as well as the CHD population and is a significant risk factor for developing 
depression. Murphy and colleagues (2008) noted in their study which followed women for 12 
months after a cardiac event that those who had anxiety were more likely to also have 
depression than those who did not have anxiety. Doering and colleagues (2011), in their study 
spanning three continents, found that women with CHD who experienced depression were 50% 
more likely than men to report also having anxiety. Such is the degree of overlap that one of the 
12 Research Planning Conferences prior to the publication of DSM-5 was dedicated entirely to 
the “comorbidity of depression and generalized anxiety disorder” (Watson, 2009, p. 222). 
Table II-3: Antecedents of depression 
Female gender Coronary heart disease diagnosis 
Other possible antecedents to depression in women 
Physiological vulnerability: 
• Genetic mechanisms 
• Younger age 
• Angina 
• Comorbid diabetes 
Psychosocial vulnerability: 
• Poor social support 
• Inability to return to work 




The consequences of both heart disease and depression in women are substantial. It has 





increased morbidity and increased mortality compared to those without depression. “Among 
women with MI or other forms of ischemic heart disease, depression is associated with an 
approximate 3-fold increased risk for death or subsequent cardiac events independent of 
severity of depression” (Mehta et al., 2016). Shah and colleagues (2014) found that depressed 
women, ≤55 years of age, had substantially higher CHD comorbidity and worse prognosis. These 
findings stress the need for more research on CHD and psychosocial factors, particularly 
depression, in young women, who are often under-represented in clinical studies of 
cardiovascular disease. 
Women also experience significant alterations in role function, self-image, and self-
management, including secondary risk factor reduction (Kronish et al., 2006; Norris & King, 
2009). Perhaps most important of these secondary risk reduction practices is exercise. Evidence 
supports depressive symptom improvement with attendance at cardiac rehabilitation (CR), 
regardless of the participant’s gender (Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure, 
2007). However, those with depression are less likely to attend CR, and less likely to complete 
CR if they do attend initially.  
Empirical Referents 
Walker and Avant define empirical referents as “classes or categories of actual 
phenomena that by their existence or presence demonstrate the occurrence of the concept 
itself” (2011, p. 168). They are “a means by which you can recognize or measure [emphasis 
added] the defining characteristics or attributes…” (Walker & Avant, 2011, pp. 168, italics 
added). As has been discussed, the screening instruments to measure the presence or absence 
of “depression” are not consistent in regard to which attributes are being measured, and prior 
work calls into question how much of these attributes are required to be clinically significant in 





standard cutoff criteria appear inadequate when it comes to measuring depression in women 
with CHD. 
Conclusions and Relevance to Clinical Practice 
As previously stated, the purpose for this concept analysis was to clarify the concept of 
depression in women following a diagnosis of CHD. A better understanding of women’s 
experiences of depressive symptoms in this population will allow more accurate diagnoses to be 
made and timely and appropriate interventions to be initiated. Based on this concept analysis, it 
appears that depression in women with CHD has been operationalized as a somatic and 
cognitive experience; only a cognitive experience; and as a pervasive affective, physical, and 
psychological experience, among many others. This concept analysis has illustrated the need to 
revisit these myriad operational definitions of depression as they pertain to this population in 
order to be more congruent with the conceptual definition as defined by DSM-5. Based on the 
literature reviewed for this analysis, women appear to experience both cognitive and somatic 
depressive symptoms but be more burdened by somatic symptoms than men, and to experience 
depressive symptoms at higher rates than men. Additionally, a specific group of symptoms (e.g., 
tiredness/fatigue, appetite disturbance, concentration difficulties, etc. - see Table 2) has been 
identified as being the most common depressive symptoms in women with CHD. Further 
qualitative studies which lend support to this group of symptoms as being the most commonly-
experienced and germane symptoms in this population is recommended. 
Women with CHD who present with antecedent conditions, including a significant family 
history of depression, younger age, angina, comorbid diabetes, poor social support, the inability 
to return to work, or comorbid anxiety should be carefully monitored for the development of 
depression as these conditions have clearly been identified with an increased risk of depression. 





depression, as these symptoms appear to be particularly salient to women’s depressive 
experience and may also be perceived as “safer” to report given the stigma still associated with 
mental illness by some (Grace, Yee, Reid, & Stewart, 2014). Screening for depression in women 
with CHD is problematic due to the multiple instruments currently used to measure the concept. 
Careful consideration should be given to the assessment instrument being used. If an 
instrument with no somatic symptoms is chosen (such as HADS or PROMIS), some other means 
of capturing these symptoms needs to be utilized and justification needs to be offered if the 
instrument is being used for research purposes. When assessing this population, using MDD 
criteria alone and excluding “minor” depression criteria to define who may need further 
evaluation may not be appropriate since this criterion is likely to miss a significant percentage of 
women who do in fact have depressive symptoms that may lead to worse outcomes. 
Consideration should be given to using different cutoff scores on depressive symptom 
assessment instruments, such as those proposed by Strik et al. (2001), Moullec et al. (2015), and 
Haddad et al. (2013) when assessing this population. 
 Several instruments which were originally developed in non-cardiac populations have been 
analyzed for use in the CHD population, including the Beck Depression Inventory I and II, the 
PHQ-9, and HADS.  Usually such analyses are performed to determine appropriateness for use in 
the population and/or optimal cutoff scores for detecting clinically significant depressive 
symptoms. However, these authors are unaware of any study which has compared the most 
used and/or recommended depressive symptom screening instruments to a diagnostic interview 
specifically in women with CHD to determine which instrument has the best Area Under the 
Curve (indicating the best sensitivity/specificity for detecting depression in the population). This 





However, thinking in the psychiatric community seem to be shifting away from the 
previously-embraced “prescriptive” approach to diagnosis. The shortcomings of drawing hard 
boundaries between mental health diagnoses and the significant overlap between such 
conditions as anxiety and depression have forced what feels like another paradigm shift in 
mental health. There is no clear consensus on the definition of depression. In a 2017 editorial, 
Stringaris (2017) noted that “psychiatrists love to argue about [the definition of depression].  . . . 
even two experienced practitioners would have a hard time agreeing on what depression is” (p. 
1287). He notes the questionable coefficient  (a statistic of agreement between raters) for 
adults in the DSM reliability field trials, situation-bound changes, the question of depressive 
subtypes, and the concern of over-pathologizing normal low mood responses. 
Still, it is undisputable that poor outcomes in women with CHD are associated with the 
group of symptoms we currently call “depression”. The cost in terms of time and money, and 
availability of resources for long diagnostic interviews will no doubt continue to prevent them 
from being routinely used in research or primary care settings. Until such time as technology 
(such as computer adaptive testing or artificial intelligence) makes screening instruments 
obsolete and/or the very definition of depression is re-written, depression screening 
instruments will continue to be used in both research and clinical settings. This analysis clarifies 
the concept of depression in women with CHD and outlines its defining attributes along with its 
antecedents and consequences. A model case, along with borderline and contrary cases, are 
provided to make identification of this concept clear. In conclusion, as CHD research moves 
forward researchers and clinicians need to be cognizant of utilizing instruments which 
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Chapter III. Manuscript 2 
 
Depressive Symptoms in Women with Coronary Heart Disease: A systematic 
review of the longitudinal literature. 
 
The role of sex/gender in coronary heart disease (CHD) has been extensively studied since 
its importance was recognized in the 1980s (Lerner & Kannel, 1986; Wenger, 1985, 1990). 
Similarly, the role of depression in CHD has been studied since the 1990s (de Miranda Azevedo, 
Roest, Hoen, & de Jonge, 2014; Leung et al., 2012; Nicholson, Kuper, & Hemingway, 2006). 
Depression is now recognized as a risk factor for poor outcomes in CHD (Barth, Schumacher, & 
Herrmann-Lingen, 2004; Leung et al., 2012; Lichtman et al., 2014). Both CHD and depression 
place a tremendous burden on women: CHD is the leading cause of death among women; 
women have poorer outcomes following a cardiac event compared to men (Doering & 
Eastwood, 2011; McSweeney et al., 2016); and women are affected by depression at a 2:1 rate 
compared to men (Mazure, Keita, & Blehar, 2002; Shanmugasegaram, Russell, Kovacs, Stewart, 
& Grace, 2012). Despite the frequent occurrence of both CHD and depression in women, 
interpreting studies about women with heart disease and depressive symptoms is challenging 
for several reasons. Women continue to be under-represented in research despite legislation 
requiring their inclusion, making interpretation of studies with small numbers of women 
problematic. Often data are not presented separately by sex/gender, so examination and 
interpretation of women’s data apart from men’s is not possible. Many studies do not look at 
depressive symptoms over time, leaving our understanding of what happens to women over 
time incomplete. Finally, the use of multiple depressive symptom assessment instruments 
makes comparisons between studies problematic. 
This state of the science review examined depressive symptom data from longitudinal 





Figure III-1: PRISMA Schema 
time-point, and reported and/or analyzed data by sex. When possible, studies were examined 
by comparing the prevalence of elevated depressive symptoms (percentage of individuals 
meeting cutoff criteria on assessment instruments) as different instruments’ results cannot be 
easily compared. Studies were also examined based on which instrument was used. For the 
purposes of this review, “sex” and “gender” were used interchangeably given the psychosocial 
influences that “gender” – a social construct rather than a biological state – may confer in the 
context of illness development and symptom experience.  
Methods 
Search Strategy 
 This literature review process 
follows the PRISMA 2009 
checklist (see Figure 1)(Moher, 
Liberati, Tetzlaff, Altman, & 
Prisma Group, 2009). A search of 
databases including Medline via 
PubMed, CINAHL, Embase, and 
PsycInfo was performed on 
February 1, 2016 and updated 
April 26, 2018 for any recent 
additions. Terms searched 








depression/exp, major depression, anaclitic depression, dysthymic disorder, endogenous 
depression, postpartum depression, reactive depression, recurrent depression, treatment 
resistant depression, and depressi*. Search limiters or filters included female, not male, English, 
humans, adult: 19+ years, longitudinal, longitudinal study, peer reviewed, and 1990-2017. 
Study selection 
Because the exploration of the role of depression in CHD began in the 1990s, the year 1990 
is used as a starting point for article inclusion. Journal articles were included if they met the 
following criteria: the study examined ischemic CHD and had a descriptive, longitudinal design; 
the study included women; depressive symptoms were assessed at more than one timepoint; 
results were reported and/or analyzed by sex; and the article was published in a peer-reviewed 
journal. This search retrieved 1,098 articles. Removal of duplicates left 723 articles. Articles were 
then excluded for the following reasons: non-research articles (such as reviews); qualitative 
articles; non-cardiac populations (such as diabetes); controlled trials (where an intervention may 
have affected depressive symptoms); studies of other cardiac conditions (transplants, heart 
failure, arrhythmia/pacer/ICDs, etc.); studies focused on risk for CHD; different phenomenon 
within CHD (such as medications, biomarkers, or ST depression); populations known to have 
high depression levels (abused women); or studies where minimal (i.e. one sentence) 
examination or reporting of data by sex was performed. One-hundred thirteen full-text articles 
were screened, and 28 hand-searched articles were identified and screened at that time. No 
grey literature was searched. Twenty articles met inclusion criteria and were reviewed and 
included in Appendix A. 
Prevalence and cutoff criteria 
When possible, studies were examined by comparing the prevalence of elevated depressive 





reviewed articles, prevalence was expressed as the percentage of participants meeting cutoff 
criteria on the depressive symptom measurement instrument used by the author. Cutoff scores 
are determined by receiver operating characteristic analysis (ROC), with the area under the 
curve representing the score with the greatest sensitivity and specificity for correctly identifying 
the presence of a condition. These scores are not diagnostic, but rather serve as a proxy for a 
clinically significant level of impaired functioning in the individual.  
Results 
Prevalence of Depressive Symptoms 
Prevalence in women at baseline. 
Of the 20 studies that met inclusion criteria, only 8 provided prevalence data on women 
participants separately from men (Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure, 2007; 
Doering, Magsarili, Howitt, & Cowan, 2006; Hunt-Shanks, Blanchard, & Reid, 2009; Josephson, 
Casey, Waechter, Rosneck, & Hughes, 2006; Lavie, Milani, Cassidy, & Gilliland, 1999; Norris, 
Hegadoren, & Pilote, 2007; Sanderson & Bittner, 2005; Shin, Hagerty, & Williams, 2010). The 
prevalence of elevated depressive symptoms in women during hospitalization for an index 
cardiac event ranged from 27.9% (Hunt-Shanks et al., 2009) to 40.3% (Norris et al., 2007), with a 
calculated average of 35.75% across the 8 studies (see Figure 2). The studies which utilized the 
Beck Depression Inventory-II (BDI-II) showed the highest prevalence: 38.8% and 40.3% in 
patients with acute coronary syndrome (ACS) and myocardial infarction (MI), respectively 
(Norris et al., 2007; Shin et al., 2010). The single study which used the Depression Interview and 
Structured Hamilton (DISH) found a prevalence of 36% prior to hospital discharge (Doering et al., 
2006). A much lower prevalence of elevated depressive symptoms (27.9%) was found in the 
study which utilized the Hospital Anxiety and Depression Scale (HADS) tool (Hunt-Shanks et al., 





of depressive symptoms prior to beginning cardiac rehabilitation (typically 2-3 weeks after 
hospital discharge) as the baseline time-point, though one additional study measured symptoms 
at this time as a second measurement time-point - “post-discharge” (Doering et al., 2006). 
Among these studies, the Beck instruments (BDI and BDI-II) demonstrated the highest 
prevalence: 36% (Josephson et al., 2006) and 31%(Sanderson & Bittner, 2005) respectively. The 
“post-discharge” study, which utilized the DISH, had a much lower prevalence of only 16.4% 
(Doering et al., 2006). 
Longitudinal prevalence among women. 
Of the 20 studies which met inclusion criteria, only 5 provided prevalence data for more 
than one time-point (Doering et al., 2006; Hunt-Shanks et al., 2009; Lavie et al., 1999; Norris et 
al., 2007; Shin et al., 2010). The average prevalence of elevated depressive symptoms among 
women across studies decreased from 35.75% during hospitalization to 27.8% 2-3 weeks post-
discharge, to a calculated average of 22.71% over the next 24 months (see Figure 2). The trend 
overall was for improvement in depressive symptoms through the first 6 months, with levelling 
off between 6 to 24 months. However, one study demonstrated a small, statistically non-
significant increase in prevalence from hospitalization (40.3%) to 12 months (40.4%) using the 
BDI-II (Norris et al., 2007). 
An examination of the available longitudinal data shows conflicting findings from 
hospitalization to one month. Prevalence of elevated depressive symptoms dropped 
significantly, from 36% to 16.4%, in a study (Doering et al., 2006) of post-CABG patients using 
DISH, but only slightly (and statistically non-significantly) from 38.8% to 26.3% in a study of ACS 
patients that used the BDI-II (Shin et al., 2010). A drop from 23% at 1 month to 12% at 4 months 
post-hospitalization in women referred to CR was noted using the Kellner questionnaire (Lavie 





prevalence from 36% at hospitalization to 12.7% at 6 months using the DISH. Hunt-Shanks et 
al.’s (Hunt-Shanks et al., 2009) study showed a smaller decline between hospitalization and 6 
months: from 27.9% to 20.6% using the BDI. However, Hunt Shanks et al. (Hunt-Shanks et al., 
2009) reported a non-significant drop from 6 months (20.6%), to 19.2% at both 12 and 24 
months. Norris et al.’s (Norris et al., 2007) study noted a small increase in prevalence from 
40.3% during hospitalization to 40.4% at 12 months using BDI-II. No differences were noted 
based on the year the study was conducted, despite significant changes to diagnostic and 
treatment approaches over the intervening years (1999 – 2010). 
 
Figure III-2: Prevalence of elevated depressive symptoms in women over time 
Sex Differences 
Prevalence in men vs women. 
Five of the twenty studies reviewed provided prevalence data for both men and women 





Shin et al., 2010). All five studies, regardless of assessment tool used, showed a higher baseline 
prevalence of elevated depressive symptoms in women than in men, and all but one study (Shin 
et al., 2010) also demonstrated a statistically significant difference between sexes (see Figure 3). 
The average calculated baseline prevalence in men across these six studies was 23.46%, versus 
34.8% in women. Of the depressive symptom assessment instruments used, the HADS showed 
the lowest baseline prevalence in both men (18.7%) and women (27.9%)(Hunt-Shanks et al., 
2009). The highest prevalence for both sexes was found using the BDI-II: 32.7% in men and 
40.3% in women (Norris et al., 2007). Three of the five studies provided prevalence data for 
both sexes beyond baseline, (Hunt-Shanks et al., 2009; Norris et al., 2007; Shin et al., 2010) with 
length of follow-up time ranging from 4 weeks (Shin et al., 2010) to 2 years (Hunt-Shanks et al., 
2009). All three studies showed a higher prevalence of elevated depressive symptoms among 
women than men regardless of assessment tool used, though not all were statistically 







Figure III-3: Prevalence of elevated depressive symptoms – women vs. men 
Non-prevalence findings in men and women at baseline. 
Twelve of the 20 studies provided mean depressive symptom scores rather than prevalence 
data (Barth et al., 2009; Bogg, Thornton, & Bundred, 2000; Brink, Grankvist, Karlson, & Hallberg, 
2005; Duits et al., 1998; Grace et al., 2005; Grace, Grewal, Arthur, Abramson, & Stewart, 2008; 
Gravely, 2007; Gupta, Sanderson, & Bittner, 2007; Lavie & Milani, 1995; McGrady, McGinnis, 
Badenhop, Bentle, & Rajput, 2009; Phillips Bute et al., 2003; Zaninotto, Sacker, Breeze, 
McMunn, & Steptoe, 2016). Of these studies, 1 measured baseline 2 weeks prior to CABG (Duits 
et al., 1998), 7 measured baseline during hospitalization (Bogg et al., 2000; Brink et al., 2005; 
Grace et al., 2005; Grace et al., 2008; Gupta et al., 2007; Phillips Bute et al., 2003; Zaninotto et 
al., 2016), 3 measured baseline prior to CR (Barth et al., 2009; Lavie & Milani, 1995; McGrady et 
al., 2009), and 1 measured baseline 45 days post-cardiac event (Gravely, 2007). Six studies (2 
post-CABG studies and 4 post-CHD hospitalization studies) found women to have significantly 





Grace et al., 2005; Gravely, 2007; McGrady et al., 2009; Phillips Bute et al., 2003; Zaninotto et 
al., 2016). One study (Gupta et al., 2007) reported only a slightly lower mean score for men 
compared to women on the BDI-II pre-CR. Three studies found no significant difference between 
men and women at baseline post-MI (Brink et al., 2005; McGrady et al., 2009) or pre-CR (Barth 
et al., 2009) using the HADS (Barth et al., 2009; Brink et al., 2005) and Kellner (McGrady et al., 
2009) questionnaires. Grace and colleagues (Grace et al., 2008) found no significant difference 
between CR participants and non-participants at baseline in their all-female study using the 
HADS. Brink et al. (2005) found women to have slightly (though statistically insignificantly) lower 
levels of depressive symptoms than men at baseline using the HADS. 
Non-prevalence findings in men and women after baseline. 
Post-baseline timepoints ranged from 1 week (Duits et al., 1998) to 2 years (Zaninotto et al., 
2016). Over half of the studies found improvement in symptoms for both genders within 3-6 
months following hospitalization, regardless of instrument used (Bogg et al., 2000; Duits et al., 
1998; Gravely, 2007; McGrady et al., 2009; Phillips Bute et al., 2003; Zaninotto et al., 2016). Two 
studies had contrary findings: Brink and colleagues (Brink et al., 2005) found significantly 
increased depressive symptom scores for both sexes between baseline and 5 months on the 
HADS after a first-time MI; and Lavie and Milani (Lavie & Milani, 1995) found a significant 
decrease in depressive symptom scores in men only following CR using the Kellner 
questionnaire. For the remaining three studies, the measurement timeframe was much broader. 
Philips Bute et al.’s (Phillips Bute et al., 2003) 12-month study using the Center for 
Epidemiological Studies - Depression scale (CES-D) found statistically significantly higher levels of 
depressive symptom both pre-CABG and 1 year post-op among women compared to men, 
though both sexes also experienced significant improvements in depressive symptoms over the 





months compared to baseline in women who had not participated in CR compared to women 
who had. Zaninotto and colleagues (2016) found that among those who had experienced angina 
or an MI in the past 2 years, women demonstrated a 13% higher probability of meeting cutoff 
criteria compared to men both at baseline and at 2-year follow-up; this decreased to 5% at 4-
year follow-up using the CESD-8 (an abbreviated version of the CES-D containing only 8 items). 
Discussion 
 This review of 20 longitudinal studies examining elevated depressive symptoms in 
women with CHD yielded several important findings. It demonstrated that the prevalence of 
elevated depressive symptoms among women at the time of CHD diagnosis was high, with a 
calculated average of 35.75% – higher than men (23%), and higher than the commonly 
perceived prevalence in the CHD population (20%), and this is true both at baseline and over 
time. Prevalence varied by measurement instrument rather than participant inclusion criteria 
(ACS, MI, PCI, general CHD), with the exception of CABG; this also held true over time. This 
review also supported the perception that most women’s symptoms do improve, and that this 
improvement largely occurs within the first 6 months after the index cardiac event. 
However, the 20 articles summarized in this review varied widely in terms of timespan 
covered (1 month - 2 years), and participant inclusion criteria. Prior research suggests that those 
who have undergone CABG tend to experience fewer depressive symptoms than those who 
have not, particularly compared to those who are medically managed after MI without 
intervention (Pajak et al., 2013) or those with unstable angina (Geovanini et al., 2014; Lotufo et 
al., 2013). Only two studies in this review focused exclusively on post-CABG patients. Of these, 
only one provided prevalence data, and this was an all-woman study. Exclusion of this study 





(35.75% with the study, 35.66% without), but it did correlate to the lowest prevalence among 
the studies at each of its follow-up timepoints (2-3 weeks, and 6 months). 
Study follow-up timeframes may have also affected results. Due to the small number of 
studies that examined symptoms beyond 6 months, the apparent improvement associated with 
this timeframe may be a reflection of the paucity of longer studies rather than actual increased 
improvement in this early stage of recovery. Stapelberg and colleagues (Stapelberg, Neumann, 
Shum, McConnell, & Hamilton-Craig, 2013) indicated that one of the main gaps in understanding 
the link between depression and CHD is failing to examine the follow-up timeframe. The authors 
are not aware of any large studies where quantitative changes in severity of major depressive 
disorder are followed at regular intervals over time. It is recommended that frequent measures 
of patient mental state be correlated over time with measures of cardiac health to provide more 
accurate longitudinal estimates of patient progress (Stapelberg et al., 2013). 
The examination of prevalence data in this review demonstrated a difference in findings 
based on instrument, with the BDI and BDI-II demonstrating much higher prevalence than the 
HADS or Kellner questionnaire. A critical difference between instruments is the inclusion or 
exclusion of somatic depressive symptoms (such as fatigue, alterations in sleep, or changes in 
appetite). Instruments which included somatic symptoms yielded higher scores. Ormel and de 
Jonge (Ormel & de Jonge, 2011) made a case for two different types of depression in CHD 
patients: “typical depression” (characterized by vulnerability and stressful life events) and 
“somatic depression” (triggered by “the presence of vascular disease, systemic inflammation 
and atherosclerosis”). A study testing their integrative model supported their conclusion:  those 
with somatic depression were at risk for increased mortality (Roest, Wardenaar, & de Jonge, 
2016). They noted that those with persistent somatic depressive symptoms were more likely to 





somatic symptoms was the results for the DISH instrument. It detected a much lower prevalence 
than the Beck instruments at baseline and pre-CR, and HADS at 6 months despite including 
somatic symptoms. This may, however, reflect the CABG population it was used with rather than 
its inclusion of somatic symptoms. 
While it appears that there is a relationship between somatic symptoms and an increased 
risk of mortality in CHD patients, it remains unclear if these somatic symptoms are depressive in 
nature or are related to the underlying heart disease itself. Both depression and heart disease in 
women can manifest as fatigue, sleep disturbances, and/or gastrointestinal symptoms such as 
appetite changes (DeVon, Pettey, Vuckovic, Koenig, & McSweeney, 2016; Doering et al., 2006; 
Kohlmann, Gierk, Hummelgen, Blankenberg, & Lowe, 2013; Sanner, Frazier, & Udtha, 2013). The 
HADS tool deliberately does not contain questions about somatic symptoms since the authors 
were concerned about confounding symptoms of physical illness with symptoms of depression 
(Snaith & Zigmond, 1986). DeVon, who evaluated ACS patients using the HADS, stated that these 
overlapping symptoms “confound [the] clinical picture” (DeVon et al., 2016). DeVon used the 
HADS specifically because it does not measure physical symptoms which could be heart disease 
rather than depression (DeVon, personal communication, October 14, 2016). Thus, while it 
appears that these symptoms are significant and should be assessed, it remains unclear whether 
they indicate depressive symptoms or rather reflect a physical disease process. Since 
management will differ depending on the symptom’s source, further investigation of the source 
of these somatic symptoms is warranted. 
The reviewed studies also demonstrated the difficulty in trying to compare findings between 
studies that use different measures of depressive symptoms. Use of item response theory and 
the development of common metrics for assessing depressive symptoms as a means to generate 





instruments, was developed using item response theory and proposed as a common metric, but 
the depressive symptom assessment instrument does not contain somatic symptoms. 
Stapelberg and colleagues (Stapelberg et al., 2013) recommend a combination of interview and 
DSM criteria-based self-report instruments to assess depression. This would facilitate a more 
accurate diagnosis of major depressive disorder, increase accuracy in assessing symptom 
severity, and potentially allow for a comparison between the two methods. Until an agreed-
upon common metric for measuring depressive symptoms is available, reporting prevalence 
data either with or without an accompanying diagnostic interview will allow simple, direct 
comparison between studies. 
This review demonstrated that women continue to be under-represented in mixed-sex 
studies of CHD, with women comprising an average of only 28.9% of study participants in this 
review. The lack of data regarding women has been reflected in other reviews (McSweeney et 
al., 2016). By not separating data by sex, the differences between men’s and women’s 
symptoms continue to be obscured due to this underrepresentation. In order to understand 
women’s unique experiences (and to create interventions which meet women’s needs), data 
must be separately analyzed and reported by sex, a practice now expected by the National 
Institutes of Health (2015). Ouyang and colleagues (Ouyang et al., 2016) also suggest 
encouraging, if not requiring, data reporting by gender by both research sponsors and journal 
editors. 
While much has been learned over the past 30 years about women with heart disease and 
comorbid depressive symptoms, this review highlights just how much remains unknown. Further 
longitudinal studies and secondary analyses of existing longitudinal data which focus on sex 
differences are needed to further elucidate women’s experiences and symptom trajectories.  





difficulty in recruiting equal numbers of women into clinical trials alongside NIH’s recognition of 
sex as an important biological variable. While use of item response theory and the development 
of common metrics for assessing depressive symptoms are underway, a simple 
solution currently for reporting this data in a manner easily comparable is to report such data as 
prevalence. These steps will provide a fuller picture of women with CHD and depressive 
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Chapter IV. Manuscript 3 
Results of a Mixed Methods Longitudinal Feasibility Study Examining Depressive 
Symptoms in Women with Coronary Heart Disease 
 
Introduction 
Understanding the role of mood in the development of and in response to the diagnosis 
of coronary heart disease (CHD) has been a significant advancement in our understanding of the 
disease. It is now believed that mood, particularly depressed mood, plays a significant role in 
outcomes following a cardiac event. Individuals who develop depression following a cardiac 
event are at increased risk for morbidity and mortality (Lichtman et al., 2014). Evidence now 
suggests that those who have depression are at increased risk of developing CHD as well (Kollia 
et al., 2017; O’Neil et al., 2016). Women are known to have higher rates of depression 
compared to men – approximately 2:1 - both in the general and the CHD populations (Moller-
Leimkuhler, 2008). 
There is a wealth of literature examining the relationship between depressive symptoms 
at the time of a cardiac event and both cardiac as well as all-cause outcomes. However, there is 
far less literature examining the trajectory of depressive symptoms in patients over time 
following a cardiac event. Even fewer studies examine data by gender and identify those who 
have met cut-off criteria on the depressive screening instruments used in the study. Those 
studies that examine gender have used a variety of depressive symptom screening tools making 
it difficult to synthesize and draw conclusions from this literature. 
Some studies suggest that somatic depressive symptoms are particularly prevalent 
among women with CHD (Peter de Jonge et al., 2006; Roest, Wardenaar, & de Jonge, 2016). 
However, the assessment of somatic depressive symptoms in the CHD population is problematic 





fatigue and sleep disturbances appear in both CHD and depressed patients, making their origin 
difficult to ascertain. Several factors have also been noted to influence the development of 
depressive symptoms in women with CHD. These include 1) age, 2) employment status, 3) 
comorbidity with diabetes, 4) attendance at cardiac rehabilitation (CR), 5) a history of 
depression, 6) a history of anxiety, and 7) acute coronary syndrome (ACS) symptoms (May Blom 
et al., 2007; Caulin-Glaser, Maciejewski, Snow, LaLonde, & Mazure, 2007; Kohlmann, Gierk, 
Hummelgen, Blankenberg, & Lowe, 2013; Kronish et al., 2006; Lesperance, Frasure-Smith, & 
Talajic, 1996; Shah et al., 2014; Smolderen et al., 2015). 
We know that some women who experience a cardiac event will experience significant 
depressive symptoms at the time of the event, others will experience such symptoms later in 
the recovery period, while others will not experience significant depressive symptoms at all. It is 
not clear what accounts for the variability in prevalence of significant depressive symptom rates 
at the time of the initial incident, the subsequent variability in recovery patterns, and the 
differences in type of symptoms experienced. Two possibilities need to be considered: 1) the 
way in which depressive symptoms are being measured, and 2) other factors influencing 
depressive symptoms. 
Materials and Methods 
The purpose of this study was to examine the feasibility of conducting a study to 
examine depressive symptoms in women ages 19 and over with CHD from the time of an index 
cardiac event (defined as myocardial infarction ([MI], acute coronary syndrome [ACS], 
percutaneous coronary intervention [PCI], or coronary artery bypass graft [CABG]) through the 
first three months of recovery, exploring depressive symptom dimensions; incidence of 
depressive symptoms; the influence of CHD and depression on sleep and fatigue; and the 






This study was guided by Lenz’s middle-range Theory of Unpleasant Symptoms (Lenz, 
Pugh, Milligan, Gift, & Suppe, 1997; Lenz, Suppe, Gift, Pugh, & Milligan, 1995). Lenz’s theory 
proposes that three factors – physiological, situational, and psychological - influence symptoms. 
Symptoms have four dimensions which are common across symptoms as well as clinical 
populations. These four dimensions are intensity (or severity), timing, level of perceived distress, 
and quality. Symptoms, in turn, influence performance (functional and cognitive activities). The 
theory also posits reciprocal relationships between the theory’s components. 
The examination of depressive symptoms in the CHD literature has largely been limited to the 
dimension of severity, though a smaller body of literature has also explored quality (somatic vs 
cognitive symptoms). For this study, a conceptual framework of depressive symptoms in 
women with CHD was proposed, applying Lenz’s model to this population (see Figure IV-
1). Depressive 
symptoms were defined as 
“the presence of a sad, 
empty, or 
irritable mood” (American 
Psychiatric Association, 
1994) after 
the cardiac event. Given that 
symptoms change over 
time as individuals adjust to 
their new health 
status, timing was 
Figure IV-1: Conceptual framework of depressive symptoms in women with 





operationalized in months, beginning at the time of the cardiac event. Severity of symptoms was 
determined by individual scores in relation to the tools’ cut-point score (which indicates 
significant functional impairment). Quality was operationalized as either somatic (physical) or 
cognitive symptoms. Symptom distress was determined utilizing the “Subjective Units of 
Distress” scale. In this study, the relationship between all four individual depressive symptom 
dimensions in women with CHD was explored, taking significant influencing factors (see Aim 4) 
into consideration. 
Specific Aims 
The specific aims of the study were as follows:  
Feasibility: Evaluate participant recruitment and retention, data collection (computer vs 
paper, instrument reliability, time burden, missing data), and uptake and data quality of 
qualitative surveys. 
Quantitative: Evaluate data for preliminary trends in the following: 
(1) the prevalence of women who meet the cut-point criteria for elevated depressive 
symptoms following a cardiac event at baseline, 2 months and 3 months post study 
enrolment as measured by 3 commonly-used tools to measure depressive symptoms, 
comparing them to prevalence rates of elevated depressive symptoms found in previous 
literature 
(2) changes over time (baseline through month 3) in women's depressive symptom 
dimensions (timing, severity, quality, symptom distress). 
(3) the influence of CHD and depression on sleep and fatigue post cardiac event at baseline, 





(4) the influence of age, diabetes, employment status, CR attendance, a history of 
depression and/or anxiety, and ACS symptoms on depressive symptoms at baseline, 2 
months, and 3 months. 
Qualitative: Explore the acceptance, uptake, and quality of a qualitative survey as a data 
collection method with a sub-sample of women who agree to participate at baseline, 2, and 3 
months post enrolment. 
Mixed methods: Describe how the qualitative data concurred with or differed from the 
quantitative depression screening instrument scores. 
Design 
This study was a longitudinal, observational feasibility study using an embedded mixed 
methods design. Both quantitative and qualitative data were collected simultaneously at each 
point in the study, analysed separately, and combined at the end of the study. An embedded 
mixed methods approach was chosen to provide a forum for women to discuss symptoms and 
their dimensions that may not have been present on quantitative data collection instruments. 
Institutional Review Board approval for conducting the study was obtained from the University 
of Nebraska Medical Center (UNMC) (#567-17-EP) and Nebraska Methodist Hospital (#1372). 
One regional hospital in a non-urban setting also served as a recruitment site under the UNMC 
IRB.  Inclusion and exclusion criteria were as follows: 
Inclusion: 
• Female sex 
• age 19 + (the age of majority in Nebraska) 
• experienced a cardiac event (MI, ACS, PCI, or CABG) during the current hospitalization 







• Diagnosis of chronic congestive heart failure (due to increased depressive symptoms in 
this population) (Rutledge, Reis, Linke, Greenberg, & Mills, 2006) 
• Any orthopedic or neurological condition which limits day-to-day physical activity (since 
these are known to limit women’s participation in cardiac rehabilitation, and non-
participation is associated with greater depression) (Supervía et al., 2017)  
• CABG within the last 6 months 
• Pregnancy or planning to become pregnant in the next 6 months (due to both altered 
physical and emotional responses during pregnancy) (Dolatian et al., 2016; Vogt et al., 
2014). 
Sampling 
Participants were recruited within one month of hospital admission via convenience 
sampling from two urban and one regional Midwestern U.S. hospital. Women who met criteria 
were identified by hospital staff and approached about study participation while in the hospital. 
The study was explained and informed consent was obtained by the principal investigator (PI) 
Buckland either face-to-face or via computer (in the case of the regional hospital).  Baseline 
quantitative surveys were either e-mailed or sent out via USPS once informed consent was 
obtained. Data were collected again 2 months and 3 months after consent. Participants elected 
to complete surveys on-line via REDCap (Research Electronic Data Capture) or on paper. 
Qualitative surveys were used to collect qualitative data, and participation in this portion of the 
study was optional. If participants elected to participate, they were asked to write for 15 
minutes on 3 out of 7 days of the same week that they completed the quantitative surveys. 
Semi-structured questions were provided. Surveys were returned to the PI along with the 







Demographic information was obtained from each participant following consent. This 
included age, race, level of education, employment, income, and marital status. Health history 
questions, including what type of cardiac event the woman was hospitalized for, and any history 
of diabetes, depression, or anxiety were also asked. Two demographics questions were asked at 
the 2 and 3-month time points: employment (whether or not the woman had held a steady job 
in the past month) and attendance at cardiac rehabilitation. 
Depressive symptom measurement instruments: 
Three depressive symptom measurement instruments were used in order to compare 
prevalence findings: the Beck Depression Inventory II (BDI-II), the Patient Health Questionnaire 
9-item (PHQ-9), and the Patient-Reported Outcomes Measurement Information System 
Depression 8b (PROMIS Depression 8b). The BDI-II is a frequently-used instrument for assessing 
depressive symptoms in the cardiac population and contains 21 cognitive and somatic items. It 
has previously demonstrated an average Cronbach’s alpha coefficient of 0.9, test-retest 
reliability of 0.73-0.96, concurrent validity with the Revised Hamilton Rating Scale for 
Depression of 0.66-0.75, and discriminant validity with the Beck Anxiety Inventory of 0.56-0.69 
(Wang & Gorenstein, 2013). BDI-II  20 is considered the typical cut-off value for this scale 
(Beck, Steer, Ball, & Ranieri, 1996). Cut-off scores indicate the likely threshold for symptoms 
creating interference in a person’s function. 
The PHQ-9 was endorsed by the American Heart Association for use in assessing 
depressive symptoms in cardiac patients (Lichtman et al., 2008), and also contains both 
cognitive and somatic symptoms. It has demonstrated internal consistency with a Cronbach 





operating characteristics curve analysis for diagnosing major depressive disorder. PHQ-9  10 is 
considered the typical cut-off value for this scale (Kroenke, Spitzer, & Williams, 2001).  
The PROMIS set of assessment instruments was developed with prior funding from the 
National Institutes of Health in order to be able to compare results of instruments across 
multiple conditions (https://commonfund.nih.gov/promis/index). The PROMIS does not contain 
somatic symptoms and has had minimal use in the cardiac population. It has previously 
demonstrated reliability with a Cronbach alpha of 0.92, convergent validity with PHQ-9 of 0.72 – 
0.81 (Pilkonis et al., 2014). Previous work suggests that instruments which do not include 
somatic symptoms yield lower prevalence rates (Buckland, Pozehl, & Yates, 2019). Since cut-off 
scores have not been established for the PROMIS tool, cut-offs based on Wahl et al.’s (2014) 
calculations for a common metric among for 11 self-report depression assessment instruments 
were used. 
Distress instrument 
Because distress is not measured as a component of any of the depression screening 
instruments, the Subjective Units of Distress measure was chosen to measure this symptom 
dimension. The Subjective Units of Distress scale is a 10-point scale where lower scores indicate 
less symptom distress and higher scores indicate more symptom distress.  The scales has 
demonstrated correlations with the State/Trait Anxiety Inventory (r=0.72, p<.05) and with the 
Multiple Affect Adjective Check List (MAACL) (r=0.59, p<.05) (Kaplan, Smith, & Coons, 1995) 
Overlapping somatic symptom assessment instruments 
Several symptoms of CHD and depression overlap, including fatigue and sleep 
disturbance. Fatigue was assessed with the Fatigue Symptom Inventory (FSI), a 13-item 
questionnaire which examines degree of fatigue as well as how much fatigue has interfered with 





convergent validity with the Profile Of Mood States (F=0.66-0.75) (Hann, Denniston, & Baker, 
2000). Sleep was assessed with the PROMIS short form v.1 Sleep Disturbance 8b (PROMIS Sleep 
8b), an 8-item scale assessing sleep disturbance. The PROMIS Sleep Disturbance 8b has 
demonstrated reliability of 0.90 and convergent validity of .083 with Pittsburgh Sleep Index (Yu 
et al., 2011). In order to ascertain whether the participant was experiencing ongoing acute 
coronary symptoms as well, the Acute Coronary Syndrome (ACS) symptoms checklist was also 
used. The ACS symptom checklist has demonstrated sensitivity of 14-72% and specificity of 33-
78% (DeVon, Rosenfeld, Steffen, & Daya, 2014). 
Analysis 
Quantitative: A fully powered study based on a priori power analysis using G*Power 
3.1.9.2 and assuming a 10% attrition rate would have required 75 participants. A feasibility 
study, according to the National Institute for Health Research, should be of a size “adequate to 
estimate the critical parameters (e.g. recruitment rate) to the necessary degree of 
precision” (Arain, Campbell, Cooper, & Lancaster, 2010, p. 4). Assuming that recruitment of 
between ¼ and ⅓ of the total number for a fully-powered study would allow for adequate 
estimation of critical parameters (recruitment rate, uptake of qualitative surveys, preliminary 
data trends), 20 to 25 participants were deemed adequate for a feasibility study. 
Quantitative data were analysed using IBM SPSS Statistics version 25. Descriptive 
statistics were used for demographic data and mean scores. Paired T-tests were used to 
examine differences in mean depressive symptoms scores between timepoints. Independent T-
tests were used to examine differences in age based on whether or not the participant met cut-
point criteria on the depressive symptom screening instrument. The quality of depressive 
symptoms – somatic vs cognitive – was determined by averaging scores of symptoms which 





does not contain somatic items, it was not included. The BDI-II categories were based on 
Thombs et al.’s (2010) article, which designates BDI-II items 1-14 as cognitive and 15-21 as 
somatic. The PHQ-9 categories were based on de Jonge, Manago, & Whooley’s (2007) article 
which identified questions 1, 2, 6, 7, and 9 as cognitive and questions 3, 4, 5, and 8 as somatic. 
For all correlations, non-parametrics using Spearman’s rho were performed due to non-normal 
distribution of the study data secondary to small sample size. 
Qualitative: Women were asked to think about and write answers to the qualitative 
survey questions on 3 of the 7 days of the same week in which they completed the quantitative 
surveys. Qualitative data was sought in order to more fully explore women’s emotional 
experiences following their cardiac event, particularly the four symptoms dimensions posited in 
the theoretical framework (symptom severity, timing, quality, and level of perceived distress). 
Terry and Braun (2017) recommend using thematic analysis for analyzing qualitative survey 
data. The goal was to explore the views of participants as expressed in their own words as a 
means of following the humanistic aim of empowerment (Jansen, 2010). Therefore, the 
approach to the data analysis was inductive (“bottom-up”) rather than theoretical (“top-down”), 
and the entire data set was analyzed rather than focusing solely on those pieces which explicitly 
addressed questions regarding the four dimensions of the theoretical framework. The six phases 
of thematic analysis as described by Braun and Clarke (2006) were followed. These are: a) 
familiarizing yourself with your data, b) generating initial codes, c) searching for themes, d) 
reviewing themes, e) defining and naming themes, and f) producing the report (Braun & Clarke, 
2006). 
Qualitative data was analysed using Atlas.ti 8 software. All journal entries were read in 
their entirety, and then re-read. Quotations of interest were identified and assigned open codes 





These themes were reviewed once all coded text had been grouped, and final themes 
subsequently named. 
Mixed Methods: Women who participated in the qualitative portion of the study were 
identified as having scored above or below the cut-point on any of the depression screening 
instruments. The originally-identified quotations for each individual theme were then examined 
based on the participant’s depression screening scores, looking for patterns in responses based 
on these scores. The themes themselves were then divided based on differences noted between 
women who had met cut-point criteria and women who had not, and quotations supporting the 
differences were provided. 
Results 
Feasibility 
Recruitment: Recruitment was problematic, due in part to issues of ethical access to the 
population.  Numerous staff members were approached about and agreed to recruit for the 
study. However, only three of the nine individuals who agreed to recruit actually 
 
Figure IV-2: Participant recruitment 
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recruited participants using the original strategy. Inclusion criteria as well as post-
admission timeframes were expanded in an effort to recruit more participants while still utilizing 
the original recruitment strategy. A revised strategy for recruitment which required less of the  
hospital staff’s time but required the PI to be at the bedside daily for participant recruitment 
was finally implemented with significant improvement in recruitment rates. Details of 
participant recruitment are provided in Figure IV-2. 
Retention: Of the 22 women who signed a consent to participate, 18 returned the 
baseline survey. At month 2, only 13 participants returned surveys. At both time points, the PI 
called those who had not returned surveys up to two times and left messages along with the PI’s 
contact information. At month 3, participants who had not returned their surveys within 1 week 
of them being sent out were mailed a written reminder to return the surveys. This increased the 
number who returned surveys to 15. This represents a 16.7% attrition from the original 18 
participants who returned baseline surveys; or 31.82% from the initial 22 who signed consents. 
Quantitative data collection: Participants were given a choice at the time of enrolment 
to complete the study via REDCap, a secure HIPAA-compliant cloud-based application designed 
to support data capture for research studies, or via paper. Of the 22 women who signed 
consents, 50% chose to do the study on-line and 50% on paper. Of those who did not complete 
the baseline data, again 50% chose on-line and 50% paper. Average data collection time (based 
on on-line responses, which were time-stamped) showed that baseline data took an average of 
17 minutes to complete, and months 2 and 3 took an average of 11 and 12 minutes respectively 
to complete. There was very little missing data. Two individual data points from two different 
participants were missing from PHQ-9. These values were substituted with the average scores of 
the non-missing items (National Health Service, 2019). One participant did not complete the 







Table IV-1: Participant characteristics 
data collection points). Because the on-line surveys required complete responses to move on to 
the next survey, there was no incomplete data from REDCap. 
Uptake and quality of qualitative surveys: 
Participation in the qualitative portion of the study was 
optional. Twelve women indicated that they would 
participate, but only six returned baseline qualitative 
surveys. This number dropped to three at month 2, and 
remained at three for month 3. Only two women 
provided qualitative survey data at all three timepoints, 
with two more providing data at two timepoints.  The 
amount of data generated per participant varied 
widely. Not all participants wrote for the 3 days 
requested. Some responses were very short - 119 words 
– and others much longer – 1,303 words. Because most 
were hand-written, the survey reposes were dictated 
into Word documents for improved readability and ease 
of analysis. 
Participant Characteristics 
Women who participated in the study ranged in age 
from 40 to 88 years old, with a median age of 6. 
Participants were predominantly white (89%), married 
(61.1%), with a high school education (44.4%). 47.1% of 





under $25,000/year, and 41.2% reported between $25,000 and $50,000 per year. 33% of the 
sample had “held a steady job in the past 6 months” at baseline. Of the admitting cardiac 
events, 27% of participants had been admitted for MI, 17% for unstable angina, 44% for PCI, and 
11% for CABG. In terms of health history, 28% of participants reported a history of diabetes; 
28% reported a history of depression; and 33% reported a history of anxiety. Of the four women 
who signed consents but did not return baseline data, 2 had undergone PCI and 2 had 
undergone CABG (see Table IV-1). 
Quantitative Data Trends 
Prevalence of Elevated Depressive Symptoms. The prevalence of women who met the 
cut-point criteria for elevated depressive symptoms on the three depressive symptom screening 
instruments (BDI-II, PHQ-9, and PROMIS Depression 8b) was evaluated. Mean scores at all 
timepoints fell below the cut-off scores for each of the scales used. Over 20% of women scored 
over the scales’ cut-offs at each timepoint (see Table IV-2). When comparing prevalence among 
individual screening instruments, the PHQ-9 prevalence was an average of 9% lower than the 
BDI-II, and 6.7% lower than the PROMIS despite its inclusion of somatic symptoms. 
Changes over time in women's depressive symptom dimensions. 
Severity: There were no statistically significant differences between severity of 
depressive symptoms (as determined by mean scores at each timepoint) on any of the three 
screening instruments at any timepoint. However, trends in changes were noted. Severity of 
depressive symptoms appeared to decrease between baseline and month 2, and then increase 
somewhat at month 3 on two of the three screening instruments (PHQ-9 & PROMIS) but 





Distress: There were no statistically significant differences between scores at any 
timepoint, but again trends in changes were noted. The average value at baseline was 3 (2.80), 
which decreased to 2.92 (2.56) at month 2, but then increased at month 3 to 3.2 (2.24). 
Quality: There were no statistically significant differences between mean scores for 
somatic and cognitive items on either the BDI-II or PHQ-9 at any timepoint. Trends in scores 
demonstrated that the mean scores for somatic items were higher than those of cognitive 
items. As with overall scale scores, mean somatic symptom scores decreased between baseline 
and month 2, but then increased from month 2 to month 3. However, mean cognitive scores 
decreased at each timepoint without an increase noted at month 3 (see Table 3). 
 
Table IV-3: Mean cognitive and somatic depressive symptom scores 
The influence of CHD and depression on sleep and fatigue. Given the small sample size 
of the study, neither ANOVA nor effect sizes could be reliably calculated. Nonparametric 
correlations using Spearman’s rho between CHD, depression (as measured by the three 
depression screening instruments), and the identified somatic symptoms were performed and 





then compared. Because all women in the study had CHD, the ACS symptom scale was used as a 
proxy for CHD. (See Tables IV-4 & IV-5 for correlation coefficients). 
 
Table IV-4: Correlation (R) between fatigue severity & interference, depression scores, and CHD 
 
 
Table IV-5: Correlation (R) between sleep, depression scores, and CHD 
Depression screening scores demonstrated significant positive correlations with fatigue 
(both severity and interference with function) and sleep. All fatigue severity and interference 
scores at a given timepoint and the depression scores at the corresponding timepoint had 
positive correlations significant at p<.005. Sleep scores at a given timepoint and the depression 
scores at the corresponding timepoint had positive correlations significant at p<.005 for baseline 





ACS scores also demonstrated significant though slightly less robust positive correlations 
with fatigue and sleep. All fatigue severity and interference scores at a given timepoint and 
the ACS scores at the corresponding timepoint had positive correlations significant at p.05. All 
sleep scores at a given timepoint and the ACS scores at the corresponding timepoint were 
significantly positively correlated at p<.05. 
The influence of demographic factors on depressive symptoms. Given the small sample 
size of the study, ANOVA could not be reliably calculated. Therefore, simple correlations 
between factors found to be significant in previous literature (age, diabetes, a history of 
depression and/or anxiety, employment status, attendance at CR, and ACS symptoms) and 
depression (as measured by the three depression screening instruments) were performed and 
then compared (see Table IV-6 for correlation coefficients). 
Age and Diabetes: There was a negative correlation significant at p<.05 noted between 
age and depression scores at baseline and month 3, though not at month 2. A more granular 
examination of the correlation between age and depression score found that the average ages 
of those who met cut-off criteria on the three depression screening instruments at baseline 
were 54.5 years (SD 14.1) for BDI-II; 46.3 years (SD 7.5) for PHQ-9; and 51.7 years (SD 12.2) for 
PROMIS. The average age of those not depressed at baseline were 69.1 years (SD 13.3) for BDI-
II; 69.4 years (SD 12.8) for PHQ-9; and 70.9 years (SD 12.7) for PROMIS. Diabetes was found to 
have significant (p<.05) positive correlation to depression at all timepoint on all screening 
instruments except BDI-II at month 2. 
History of depression or anxiety: Having a history of depression was found to be 
significantly (p<.05) positively correlated with current depression screening scores baseline and 
month 3 for all instruments except BDI-II at baseline. None demonstrated significant 





depression screening scores, with significant (p<.05) positive correlations at all timepoints on all 
instruments except BDI-II at 
month 2.  
Cardiac Rehabilitation 
attendance, employment 
status, and acute coronary 
syndrome symptoms: 
Depression scores at all 
timepoints on all screening 
instruments demonstrated a 
significant (p<.05) negative 
correlation to cardiac 
rehabilitation (CR) 
attendance at month 2, and 
scores at baseline and 
month 3 (but not month 2) 
on all depression screening 
instruments had a significant 
(p<.05) negative correlation 
to cardiac rehabilitation (CR) 
attendance at month 3. 
Those whose depression screening scores were higher (meaning more depressive symptom 
burden) were less likely to attend CR. ACS symptoms demonstrated a significant (p<.05) positive 
correlation with depression screening scores on all instruments at all timepoints, though the 3-





month depression screening scores demonstrated the strongest correlation to ACS symptoms at 
any timepoint, reaching a significance of p<.005 on all three instruments. Employment status did 
not show any significant correlation to depression screening scores at any timepoint, contrary to 
previous literature. 
Qualitative Data Findings 
Three main themes were identified from the qualitative survey data: 1) health care 
system interactions, 2) social engagement, and 3) individual response to the health event. 
Women described experiences that negatively impacted their mood. First women felt angry or 
upset because of poor interactions with their physicians. 
06: “Dr. [X] hollers at me.” 
06: “… the cold wind makes my chest hurt and has for several years. Doctor [X] says to 
just live with it…” 
 
14: “I think the very worst part of my heart problems is that doctors look at me like I’m a 
menopausal woman who doesn’t know what I’m talking about. They make me feel fat 
and lazy because there are so many things I used to love to do that I can’t do 
anymore. The very worst thing is being lumped in and called a drug seeker! I have better 
stuff at home - why the hell would I care about their drugs?” 
The health care system was also a source of distress for women related to insurance and lack of 
adequate coverage. Though she never states her frustration directly, one participant describes 
more than one instance where poor insurance coverage prevented her from getting the care she 
would otherwise have sought, such as secondary prevention. 
06: “Heart Dr. wants me to do heart rehab exercise but I can’t. My insurance won’t pay.” 
In another instance she experiences a frightening health-related episode and concludes, 
06: “No I didn't go to the doctor - it was Saturday and ER would have run a million 
dollars + tests and I have [name of insurance] that doesn't pay it all.” 
Good relationships with care providers were also described that supported women’s emotional 
well-being. 
09: “Felt very relieved that the heart cath. went well because of my allergy to IV contrast 
dye.  Can thank Dr. [X] for his protocol that prevented a severe reaction.” 
09: “I was so grateful for the excellent care I received in the hospital.  I felt confident and 





22: “It is an encouragement to me to have the coronary artery disease diagnosed and a 
treatment plan begun.  It was worrisome not to know for sure what was causing my 
extreme fatigue.” 
The second theme, identified was social engagement. Every woman in the study wrote 
about how the level of social interaction affected her feelings. Several women noted that it was 
in the moments when they were alone that they felt most down. Women valued contact with 
family, but the a lack of family members close-by to created loneliness and isolation. Widowed 
women found the absence of their spouse to exacerbate feelings of loneliness and isolation.  
06: “I lost my husband in April, don’t have any ‘real’ friends to do things with so when I 
come home from work its Blah.” 
07: “Emotions –evenings are hard, my [late] husband and I always watched TV together 
in the evenings. … [My sons] know evenings are my worst time, (alone) they call, and lift 
my spirits.” 
14: “I really miss my family and my best friend lives in [far away state] and the one sister 
I'm closest to lives in [far away state] so we don't see each other all I can do is text 
everybody.”  
Social interaction with friends and family were described by women as “perking them up” and 
lifted their mood. 
06: “Got up in a good mood. 2 of my out of town friends called last night.” 
11: “I did notice that my feeling + mood did change.  I feel tired if I start worrying why 
my children haven’t called. …So, I took time off, called a friend and asked her if she can 
send her son to my house.  He is nine years old. I have him help me put videos away or 
organize them.  He tells me about school, we go to the store, take a walk at the park.  
And by the time I notice, [my worry] all goes away.” 
 09: “Over the course of the last several days, I have heard from lots of my friends… It 
was great to hear from each and every one.  Several, [names of friends], also came to 
visit.  Friends are real blessing.” 
22: “Interacting with people usually perks me up and I forget the tiredness or get a boost 
of energy.” 
The last theme was individual response to the health event. These emotional responses 
stemmed from women’s perceptions of their own health and whether it had significantly 
changed. Changes were often described in terms of emotional responses to somatic and 
cognitive symptoms. Disappointment was expressed over experiencing unexpected fatigue 
following their cardiac event. 
22: “I think I expected a significant improvement in my energy level after the stent was 





makes me consider the likelihood that I may not experience a return to full energy and 
motivation.” 
06: “Everyone says ‘Oh should feel better now.’ I didn’t feel bad before but now I seem to 
have fatigue more – a lot more.” 
Another participant lamented her loss of physical function. 
14: “...there are so many things I used to love to do that I can’t do anymore.” 
14: “I can't walk very far or very fast because of my heart and my hips” 
More than one participant expressed anhedonia and problems with concentration or focus that 
then led to depressed mood. 
07: “I’m feeling more depressed than usual. I don't enjoy things like I used to.” 
22: “I don’t care about anything” is the best way I can describe the mood and I would say 
it has been significant.” 
22: “I feel like my brain is wandering and I am having trouble with focus.  Also, I feel very 
fatigued and simply don’t want to do anything focused.” 
Feeling “down”, self-dislike, and crying were also described. 
14: “I don’t look in the mirror anymore.  I don’t care for my body as much now.” 
14: “I’m so used to feeling down I guess I don’t notice things as much.” 
06: “I cry a lot – lonesome (?), Sad (?) don’t know –teary as I write now” 
These experiences were not universal, however. Some participants felt that their cardiac event 
did not have a significant impact on their emotions and denied any somatic or cognitive 
symptoms. 
09: “My general feelings remain positive with no depression at all.” 
11: “I haven’t lost interest in doing activities, going places, and seeing people.  I don’t 
blame my mood or feelings on my heart disease.  I blame them on situations or things 
that occur.” 
Mixed Methods Results 
The purpose of conducting a mixed-methods analysis was to compare the qualitative 
and quantitative data, looking for similarities and differences. Of particular interest was whether 
women who met cut-off scores on depression screening tools provided substantively different 
responses to women who did not. At baseline, four of the six women who provided qualitative 
survey data met cut-off scores on at least one of the depression screening instruments. At 
month 2, two of the three women met cut-off scores, and at month 3, one of the three women 





Findings of the mixed methods analysis are summarized in Table IV-7. The theme health 
care system interactions demonstrated a clear pattern based on depression screening scores. 
Participants who scored below cut-off on depression screening instruments had positive 
interactions with the health care system, and those whose depression screening scores were 
above cut-offs had negative experiences with the health care system. 
These results did not hold regarding social engagement. Women universally agreed that social 
engagement lifted their mood, and that the times they were alone were more difficult 
emotionally. The difference between women who did or did not meet cut-off criteria in this 
category appeared to be two-fold: 1) the woman’s perceived availability of social contact, and 2) 
the woman’s internal motivation to seek contact. Those who perceived less availability of social 
contact had higher depression screening sores. Those who had more internal motivation for 
seeking social contact had lower depression screening scores. One participant whose depression 
screening scores were above cut-off values wrote frequently about social engagements, but also 
frequently lamented about how alone she was. She did not write about seeking out contact. 
Other participants who did not meet cut-off criteria on depression screening instruments wrote 
about making themselves engage. One wrote, “I just have to get up and do something”. Another 
stated, “I tend to push through it…”. 
Finally, the theme individual response to the health event demonstrated mixed results. 
Women who denied changes in their feelings due to the change in their health status all scored 
below cut-off on depression screening. However, those who did report changes in feelings after 
their cardiac event had depression screening scores both above and below cut-off values and 
expressed experiencing both somatic and cognitive symptoms in their qualitative surveys. 
Theme Depression 
score ≥ or < 
cutoff 
Supporting qualitative data 







my allergy to IV contrast dye.  Can think Dr. [X] for his 
protocol that prevented a severe reaction.” 
• “It is an encouragement to me to have the coronary artery 
disease diagnosed and a treatment plan begun.  It was 
worrisome not to know for sure what was causing my 
extreme fatigue.” 
• “I was so grateful for the excellent care are received in the 
hospital.  I felt confident and comfortable with Dr. [X] and 
Dr. [Y] doing the heart cath and the angioplasty.” 
  ≥ cutoff • “I think the very worst part of my heart problems is that 
doctors look at me like I’m a menopausal woman who 
doesn’t know what I’m talking about. They make me feel 
fat and lazy because there are so many things I used to love 
to do that I can’t do anymore. The very worst thing is being 
lumped in and called a drug seeker! I have better stuff at 
home - why the hell would I care about their drugs?” 
• “Dr. [X] hollers at me.” 
• “No I didn't go to the doctor - it was Saturday and ER would 
have run a million dollars + tests and I have Humana that 
doesn't pay it all.” 
2 social-level 
engagement 
< cutoff • “Interacting with people usually perks me up and I forget 
the tiredness or get a boost of energy” 
• “Over the course of the last several days, I have heard from 
lots of my friends… It was great to hear from each and 
every one.  Several, [names of friends], also came to 
visit.  Friends are real blessing.”  
• “I did notice that my feeling + mood did change.  I feel tired 
if I start worrying why my children haven’t called. …So, I 
took time off, called a friend and asked her if she can send 
her son to my house.  He is nine years old. I have 
him help me put videos away or organize them.  
He tells me about school, we go to the store, take a walk at 
the park.  And by the time I notice, [my worry] all goes 
away.” 
  ≥ cutoff • “I'm alone except for work. Sometimes the neighbor brings 
food but not often. I go to church but nobody there checks 
on me. Guess that's why I work - get out and see people.” 
• “Wally & I drove to Paxton to eat turkey dinner. He said I 
needed to get outta town and it was nice.” 
• “I really miss my family and my best friend lives in New 
York and the one sister I'm closest to lives in Ohio so we 
don't see each other all I can do is text everybody.” 
• “I've been feeling very down lately...I feel like [my 
husband] doesn't really care about my heart anymore. I do 
what I can but he just doesn't get it. … He thinks this is just 
a game I'm playing for attention.  He’s also refused to take 






















• “My general feelings remain positive with no depression at 
all.” 
• “I haven’t lost interest in doing activities, going places, and 
seeing people.  I don’t blame my mood or feelings on my 
heart disease.  I blame them on situations or things that 
occur.” 
 
• “I think I expected a significant improvement in my energy 
level after the stent was put in place.  While the shortness 
of breath has improved, I still feel the fatigue and this 
makes me consider the likelihood that I may not 
experience a return to full energy and motivation.” 
 
• “I’m feeling more depressed than usual. I don't enjoy 
things like I used to.” 
•  “I don’t care about anything” is the best way I can describe 
the mood…” 
• “I feel like my brain is wandering and I am having trouble 
with focus.  Also, I feel very fatigued and simply don’t want 
to do anything focused.” 






• “Everyone says ‘Oh should feel better now.’ I didn’t feel 
bad before but now I seem to have fatigue more – a lot 
more.” 
• “I can’t walk very far because of my heart and my hips” 
• “I’ve been eating way too much to try and fill the hole I feel 
inside.” 
 
• “I cry a lot – lonesome (?), Sad (?) don’t know –teary as I 
write now.” 
• “I worry a lot about the future” 
• “I’m so used to feeling down I guess I don’t notice things as 
much.” 
• “I don’t look in the mirror anymore.  I don’t care for my 
body as much now.” 
 
Table IV-7: Mixed Methods results 
Discussion 
This study provided important information about the feasibility of the utilized 
recruitment strategies, retention strategies, and the use of qualitative surveys for qualitative 
data collection, and adds important detail to our understanding of depressive symptoms in 





be identified and available on-site for participant recruitment. Anticipation of a 20-30% attrition 
rate would be a more reasonable assumption given these initial results. Attrition after baseline 
did not seem to improve with phone calls, but did with written reminders to return surveys. 
Therefore, a plan to send written reminders to those who have not returned data may be a good 
strategy to minimize attrition. The use of REDCap as a means of data collection was not a 
significant improvement over paper in this population, though no missing data occurred with 
use of REDCap. Continued use of both methods depending on participant preference appears to 
be a reasonable strategy. Length of time to complete surveys was actually quite short, 
demonstrating minimal participant burden. 
These authors would make several changes to the approach used with qualitative 
surveys as a method of qualitative data. First, more open-ended survey questions would be 
beneficial so that women would feel more at liberty to write what came to mind about their 
emotional experiences. Next, iterative revisions to the survey at each timepoint would help to 
ensure that the desired information was being generated. Finally, the importance of following 
through with qualitative surveys if the participant indicated they would participate should be 
emphasized during the consenting process, perhaps attached to a larger incentive for the 
participant given the poor return rate for qualitative surveys despite stated interest. The costs 
and benefits of doing serial interviews with select participants should be weighed against this 
less time-consuming but also less controllable (and, at least in this feasibility study, less reliable) 
method of data collection.  
The depressive screening instrument data from this study demonstrated prevalence 
rates similar to previous studies. The average prevalence of depressive symptoms at baseline in 
this study (30%) was slightly lower than the 36% found during hospitalization but slightly higher 





systematic review of longitudinal literature on depressive symptoms in women with CHD. The 
review found an average prevalence of 27% at 1 month, similar to the prevalence found in this 
study at 2 months (26%). The 3-month prevalence in this study (25%) is far higher than the 12% 
prevalence found at 4 months in the review (though this timepoint was represented by only 1 
study). 
A more granular examination of individual instruments yielded unexpected findings: the 
BDI-II and PROMIS Depression 8b yielded more similar results than the BDI-II and PHQ-9, despite 
the PROMIS not including somatic symptoms.  This is in contrast to the finding of lower 
prevalence among instrument which did not contain somatic symptoms in Buckland, Pozehl, & 
Yates’ (2019) review. 
Some authors have argued that including somatic symptoms on depression screening 
instruments confuses the clinical picture and makes correct diagnosis more difficult (DeVon, 
personal communication, 2014; (Snaith & Zigmond, 1986). Others point to these symptoms as 
indicators of potential worse outcomes in CHD patients (de Miranda Azevedo, Roest, Hoen, & de 
Jonge, 2014) or as a means of deciphering the underlying CHD from depression (McGuire, 
Eastwood, Hays, Macabasco-O'Connell, & Doering, 2014). Given the performance of the PROMIS 
Depression 8b in this study, this instrument may provide measures similar to somatic item-
containing instruments. However, because of such small numbers of study participants this may 
be more a reflection of a small sample than actual meaningful differences. A repeated 
evaluation of these same measures in a larger sample size is needed. 
The differences in depressive symptoms scores over time did not reach statistical 
significance in this study, again likely due to the small sample size. However, severity of overall 
depressive symptoms in this sample yielded an interesting trend. There was a trend toward 





month 3 on two of the three instruments (PHQ-9 and PROMIS). This same trend was reflected in 
the measure of distress as well. Even if the 3-month data from those who did not respond at 
month 2 are removed, the mean scores on PHQ-9 and PROMIS remained higher at month 3 than 
month 2. Interestingly, this trend seemed to reflect the changes in somatic depressive 
symptoms but not cognitive symptoms, which continued to decrease across all time points. 
Somatic symptom scores were higher than cognitive scores in this study, supporting the idea 
that somatic symptoms in women are of particular importance. These differences and 
depressive symptom trends should be interpreted with caution and would need to be validated 
in a larger sample. 
The significant overlap between the somatic symptoms of sleep disturbance and fatigue 
was examined in this feasibility study. This preliminary examination of these symptoms 
demonstrated that there was a significant correlation between the depressive screening scores 
and both fatigue and sleep. This is consistent with previous findings (Doering & Eastwood, 2011; 
Frazier et al., 2012; Sanner, Frazier, & Udtha, 2013). Though not a specific study aim, individual 
scale analysis showed that the items with the highest mean scores on the BDI-II and PHQ-9 in 
this study were somatic symptoms: sleep changes, fatigue & loss of energy, appetite changes, 
and loss of interest in sex. The only cognitive symptom with a similarly high mean score was 
anhedonia. Changes in thinking regarding depression have led some to recommend more focus 
be placed on individual symptoms versus sum scores: individual symptoms may be more 
reflective of underlying biology and may also affect the degree of impairment of the individual 
(Fried & Nesse, 2015). A recent study by Carney et al. (2018) examining residual depressive 
symptoms in the CHD population after treatment with 6-12 sessions of individual cognitive 
behavior therapy (CBT) found that loss of energy (69.1% of participants) and fatigue (55.6% of 





only other symptom to affect >50% of participants post-treatment, was anhedonia (51.6% of 
participants). Thus, the feasibility study findings appear to be consistent with other study 
findings, but they are also concerning since these women appear to be experiencing the 
symptoms that are most resistant to treatment (Carney et al., 2018). 
A significant though less robust correlation between ACS and sleep disturbance and 
fatigue was also found. These correlations support those found in previous literature on physical 
symptoms in CHD (Kohlmann et al, 2013). However, fatigue is a component of the ACS symptom 
checklist, so its measurement with this instrument may be redundant (DeVon et al, 2014). For 
this reason, a different measure for CHD such as the Duke Coronary Artery Disease Index (Mark, 
Nelson, Califf et al., 1994) or a biomarker risk score (Ghasemzedah et al., 2017) may be a better 
choice. If this component of the study were to be repeated in the future study, a different 
measure for CHD would likely need to be identified. 
Several factors have been found in prior research to influence the development of 
depressive symptoms in CHD patients. The preliminary results from this study demonstrated 
very robust negative correlations between depression scores and participant age. Consistent 
with prior research, depression appears to be worse in women who develop CHD at a younger 
age (Mallik et al., 2006; Sanner et al., 2013). In this study, the average age of women who met 
cut-off criteria for depression on the screening instruments was nearly 20 years younger than 
those who did not. At age 46 (the mean age of the younger women in  this study), women are 
more likely to still be working, may still have children at home, may be caring for grandchildren 
and/or be caring for aging parents. A significant change in health status may be quite disruptive 
to these women's’ roles and responsibilities, decreasing their ability to provide both tangible 
and emotional support to their families. A recent study looking at perceived stress post MI in 





initially and over the next 12 months compared to men (Xu et al., 2017). Shah et al.’s (2014) 
study examining the association of depression with CHD and adverse cardiac events found a 
correlation between depression and CHD and risk of death in women age ≤ 55. These findings 
suggest that not only are younger women with CHD struggling, but their lives may be at risk if 
they develop clinically significant depression. 
The results from this study also demonstrated very robust positive correlation between 
depression scores and diabetes. This is also consistent with previous research (Murphy et al., 
2008; Pajak et al., 2013). The correlation between diabetes and depression, even without the 
presence of CHD, has been found to be significant (Kanapathy & Bogle, 2019). CHD co-morbidity 
with diabetes may be more depressogenic due to the difficulty of managing diabetes and the 
mental burden of having two significant chronic medical conditions. The combination of 
diabetes, depression, and CHD also puts women at even greater risk of poor outcomes than 
diabetes and depression alone (Pan et al., 2011).  Research exploring a possible common root 
cause for both CHD and diabetes has been a topic of interest, leading to studies of genetic 
overlap (Amare, Schubert, Klingler-Hoffmann, Cohen-Woods, & Baune, 2017) as well as 
development of systems biological models (Stapelberg, Neumann, Shum, McConnell, & 
Hamilton-Craig, 2015). Women experiencing comorbidity with diabetes and CHD will need 
significant amounts of education, close follow-up, and both tangible and emotional support. The 
importance of exercise in improving diabetes, depression, and CHD needs to be clearly 
conveyed. 
A history of anxiety also demonstrated a significant correlation to depression scores on 
all screening instruments at all timepoints except BDI-II at month 2. Prior research has found 
comorbidity of depression and anxiety to be common, particularly in women, and this appears 





Schenck-Gustafsson, 2007; van Montfort, Denollet, Vermunt, Widdershoven, & Kupper, 2017). 
Prior studies have also shown a history of anxiety to be a significant predictor of subsequent 
depression in CHD patients (Murphy et al., 2014; Schrader, Cheok, Hordacre, & Marker, 2006). 
Interestingly, this feasibility study demonstrated a stronger association between a history of 
anxiety and current depression than a history of depression and current depression (though 
both demonstrated significance at more than one timepoint). This may be a reflection of small 
participant numbers, and more participants with a history of anxiety than depression in this 
study. A recent scoping review of risk factors for depression in individuals with CHD found a 
history of depression to be a stronger predictor of subsequent depression than a history of 
anxiety (Greenman et al., 2018). Given the small sample size in this study, results should be 
treated as preliminary and interpreted with caution. 
This study found a strong correlation between depressive symptom scores and 
attendance at cardiac rehabilitation, with women who had higher depression scores attending 
cardiac rehabilitation less than those who had lower scores. This is consistent with prior 
literature showing that women with greater depressive symptom burden are less likely to 
complete cardiac rehabilitation (Sanderson & Bittner, 2005). In a systematic review of studies 
examining the effects of exercise on depression in CHD patients, exercise has demonstrated 
improvement in depression both in the short and long term in those with increased levels of 
depression (Verschueren et al., 2018). Even in women with microvascular disease, a relatively 
recently discovered and still poorly understood condition more often affecting women than 
men, exercise appears to improve quality of life (Szot, Zając, Kostkiewicz, Owoc, & Bojar, 2015). 
This underscores the importance of screening for depressive symptoms prior to discharge so 
that women who demonstrate elevated symptoms receive targeted emphasis on the benefits of 





No significant correlation was noted between depression and employment status in this 
study. This was an unexpected finding. A recent meta-analysis of observational studies 
examining risk factors for post-ACS depression found that “housewife status” was a risk factor 
for developing depression whereas being employed was protective (Mei-zhen et al., 2019). This 
lack of correlation may be related to the way this question was posed in the survey. Women 
were asked if they had held a steady job in the past 6 months – “yes” or “no/retired”. Because 
those who are not working by choice (retired) may feel quite different from those who are 
involuntarily unemployed, this answer choice may have masked the negative feelings of those 
who were unemployed but desired to work. A future study will need to change wording to 
ensure that responses separate those who are unemployed by choice from those who are not. 
Depressive symptom scores also correlated with ACS symptoms in this study. Angina in 
particular has been associated with higher depressive symptom burden in prior studies 
(Jespersen, Abildstrom, Hvelplund, & Prescott, 2013; Sundel et al., 2007). A meta-analysis of 
studies across 31 countries demonstrated that women were more likely to experience angina 
than men (Hemingway et al., 2008). Angina appears to be a more significant problem in those 
who do not have “classic” coronary artery disease which is amenable to intervention such as 
stenting or bypass (Jespersen, Abildstrom, Hvelplund, & Prescott, 2013). Because non-
obstructive disease is more common in women (Pasupathy, Tavella, & Beltrame, 2016), women 
appear to be at higher risk of developing associated depression. Evidence-based therapies for 
people who experience cardiac ischemia without obstruction (INOCA) are just evolving, and the 
Cardiovascular Disease in Women Committee of the American College of Cardiology have 
developed an agenda to advance this area (Bairey Merz, Pepine, Walsh, & Fleg, 2017). Follow-up 
visits need to include assessment of ongoing ACS symptoms to identify women who may be at 





Interactions with the health care system are unavoidable for those who have a chronic 
illness. Relationships with care providers may either encourage or discourage women from 
successfully managing their health. Likewise, financial concerns and insurance coverage issues 
may prevent women from following through with important secondary risk reduction such as 
cardiac rehabilitation. Social isolation, particularly for women who have lost their spouses or 
who do not have family close by, may have a significant negative impact on women’s mental 
health. Isolation may be exacerbated if they have experienced a decline in physical health as a 
result of their cardiac event. Conversely, interactions with friends and family appear to have a 
very positive affect on mental health. Assessing women’s social support following a cardiac 
event may be important for determining risk for poor mental health. Finally, women had varied 
responses to their health event. Some appeared to feel as if their health was largely unchanged 
after their cardiac event.  Other women who experienced somatic and/or cognitive symptoms 
following their cardiac event seemed to feel that their cardiac event signalled a significant 
change in their health. Cultivating a positive relationship with these women will help elicit these 
responses and significantly aid in individualizing care. 
There does appear to be a relationship between increased depressive symptom burden 
and a negative relationship with the health care system, poor perceived social support, and a 
perception of changed health status following the cardiac event in this population. While it is 
unclear if the depressive symptoms caused these issues or were the result of these issues, 
previous research is clear in regards to increased depressive symptom burden leading to worse 
health outcomes. Unfortunately, prior research attempting to modify perceived social support 
and depression has not yielded significant improvements in morbidity and mortality. The 
landmark ENRICHD study, which examined the effects of treatment for low perceived social 





treatment with cognitive behavioural therapy found improvements in psychosocial outcomes 
but no significant difference in “event-free survival” after an average follow-up period of 29 
months (Berkman et al., 2003). Since that time, other studies have explored peer support 
interventions (Colella & King-Shier, 2018), stress management via group sessions (M. Blom et al., 
2009), and online community building to increase risk-modifying behaviour (Richardson et al., 
2010), with minimal success. Other researchers have looked at the possible effects of depressive 
symptom clusters on adherence outcomes (Versteeg, van Montfort, Denollet, & Kupper, 2016) 
and the relationships between social strain, social support, quantity of social ties and multi-
system risk (via allostatic load) (Seeman, Gruenewald, Cohen, Williams, & Matthews, 2014). The 
research community has yet to discover scalable interventions which improve depressive 
symptoms, perceived social support, and cardiovascular outcomes.  
Strengths and Limitations 
One of the strengths of this study is recruitment of women from three different types of 
institutions - a large urban public hospital, a large urban private hospital, and a smaller regional 
hospital – providing a wide representation of women despite its small size. This study adds 
needed granular details regarding depressive experiences of women with CHD over time to the 
existing literature. It also provides a preliminary assessment of one of the PROMIS Depression 
short form tools in the CHD population. The mixed methods design produced qualitative data 
showing that women with higher depressive symptom scores report different experiences post 
cardiac event than women who experience fewer depressive symptoms.  
There were several limitations to this study. The small sample size limited the statistical 
analyses that were possible to perform, particularly estimating an effect size for influence of 
CHD and depression on two common overlapping somatic symptoms. Poor uptake of the 





assess who was and was not on antidepressant medications and/or undergoing counselling for 
depression at the start and during the study. This may have influenced outcomes. The grouping 
of retired and unemployed women together may be responsible for the lack of correlation 
between depression scores and employment, as those who are unemployed by choice may feel 
very differently about their status than those who are not working because they are not able.  
Conclusions and Future Recommendations 
These study findings suggest that the PROMIS Depression 8b may be an excellent choice 
of instrument for those who have significant concerns about measuring somatic symptoms and 
wish to choose an instrument that does not contain somatic items since it demonstrated 
prevalence similar to BDI-II. Performance of the PROMIS Depression 8b in the female CHD 
patient population would benefit from further examination in a larger sample. A dedicated 
study examining ROC curves for sensitivity and specificity of the PROMIS Depression 8b versus 
other measures containing somatic symptoms compared to diagnostic interview findings in this 
population would also be beneficial.   
The finding that overall mean depression scores as well as distress scores trended in the 
same direction as the somatic symptom scores supports the centrality of somatic symptoms in 
women’s experience of depressive symptoms but also suggest that women in particular may be 
at increased risk of having residual depressive symptoms, even if they receive appropriate 
treatment (Carney et al., 2018). A multi-modality approach may be required to alleviate these 
somatic symptoms given the difficulty in treating them to remission with CBT alone (Carney, 
2018). The study findings also suggest that ongoing assessment of depressive symptoms in 
women in this population is important since depressive symptoms are associated with worse 
outcomes (Lichtman et al., 2014). The role of somatic depressive symptoms in this population 





further which specific symptoms are most often reported, by whom, and which remain 
unresolved following treatment will aid in development of approaches which can target these 
symptoms, preventing persistent depression and potential worse outcomes. 
This and other prior research have demonstrated that younger women with CHD 
experience much more depression than older women. Studies which elucidate younger 
women’s depression risk factors are needed to determine which are amenable to intervention. 
Women with comorbid diabetes are another group who clearly demonstrated more depression 
in this study than women who do not have diabetes. The co-occurrence of depression in multi-
morbid individuals is not a unique finding to this study.  Because diabetes, depression, and CHD 
all respond positively to physical activity, studies comparing different strategies already shown 
to promote physical activity in this population should be undertaken. 
The strong correlation between baseline depressive symptom scores and attendance at 
cardiac rehabilitation has implications for post-discharge care of these cardiac patients. This 
relationship suggests that women who are depressed early on after their cardiac event may not 
be as attuned to care needs later on in the recovery period. The importance of attending cardiac 
rehabilitation needs to be emphasized to women who screen positive for elevated depressive 
symptoms either during their hospital stay or at their initial follow-up appointment since these 
women appear to be at significant risk of non-attendance. 
Intervention studies which address depressive symptoms and low perceived social 
support in women with CHD that also improve cardiovascular outcomes and are scalable 
continue to be needed. Finally, dedicated efforts to include women and men in equal numbers 
in CHD studies and data analysis by gender in all manuscripts from studies which include both 
men and women participants need to be priorities in CHD research moving forward if we are to 
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The literature on depressive symptoms in women with CHD, though significantly more 
substantive since the mid-1990s, continued to demonstrate some important gaps. The concept 
of depression in women with CHD itself was problematic, and information regarding what 
happens to depressive symptoms in women over time was also lacking. Chapter two of this 
dissertation provided a concept analysis of depression in women with CHD, following the steps 
laid out by Walker and Avant (Walker & Avant, 2011).  The mismatch between the actual 
concept and the operational definition of the concept as represented by the depression 
screening instruments was discussed. Key attributes of depression in women with CHD were 
identified, along with actual and potential antecedents. Finally, the importance of applying 
these findings to research and practice was discussed. 
Literature Review 
Chapter three of the dissertation provided a systematic review of the longitudinal 
literature on depressive symptoms in women with CHD. Following PRISMA guidelines, twenty 
articles met inclusion criteria for this systematic review. The key findings from this review were 
that 35.75% of women experience depression at the time of CHD diagnosis but most appear to 
improve over the first 3-6 months. However, this may be a reflection of few studies extending 
beyond 6 months. Women also experience more depression than men both at the time of 
diagnosis and across time. The instrument used to measure depressive symptoms had a 
significant impact on findings, with instruments measuring somatic symptoms yielding 
significantly higher prevalence than those that did not (with the exception of results in the 





be under-represented in CHD studies and lack of data analysis by gender also continues to be a 
gap. 
Dissertation Study 
Chapter four of the dissertation reported results of the feasibility study examining 
depressive symptoms in women with CHD over time. The aims of this study included a) 
evaluating the feasibly of enrollment and data collection strategies used in this study, b) 
evaluating the quantitative data for preliminary trends, and c) evaluating the qualitative data 
collection method and the data generated via this method. 
Feasibility Aims 
The feasibility aims of this study included evaluating enrollment (recruitment strategies 
and efficiency, attrition, problems and solutions) and data collection (use of REDCap vs paper, 
instruments reliability, time required, missing data). Recruitment was problematic, due in part 
to issues of ethical access to the population. A successful strategy was finally discovered which 
minimized time demands for those identifying potential participants, but also required the PI to 
be available at the bedside. Prior research has demonstrated that recruitment for research is a 
significant problem. A recent review of phases 2 and 3 intervention clinical trials that ended in 
2011 and were registered with the National Library of Medicine clinical trial registry found that 
19% - nearly 1 in 5 - “either terminated for failed accrual or completed with less than 85% 
expected enrolment [sic]” (Carlisle, Kimmelman, Ramsay, & MacKinnon, 2014, p. 77). Very little 
data is available on nursing research specifically. An article by Badger and Werrett (2005) out of 
the UK examining nursing research published in 2002 in one of three journals (Journal of 
Advanced Nursing, Journal of Clinical Nursing, or International Journal of Nursing Studies) found 





articles respectively. This author’s experience and the statistics regarding recruitment support 
and highlight the importance of feasibility work prior to beginning a fully-powered study. 
Attrition was also a problem which was exacerbated by the small number of 
participants. Month two, the timepoint with the fewest participants (13), represented a 28% 
attrition rate from the 18 who returned baseline surveys (or 41% from the 22 who signed 
consent forms) despite the time burden for survey completion being minimal (ave. 20 
minutes). According to the literature, the average rate of attrition across all types of clinical 
trials is 30% (Lopienski, 2015). Longitudinal studies report attrition rates between 30-70%, with 
longer studies generally experiencing greater attrition (Gustavson, von Soest, Karevold, & 
Røysamb, 2012). From this perspective a 28% attrition rate is not unusual, though with a small 
number of study participants results are much more likely to be impacted. The qualitative 
portion of the study demonstrated higher attrition, with only 50% of the original journaling 
participants at baseline still submitting journal entries at month three. SmithBattle and 
colleagues recently performed a methodological review of 77 qualitative longitudinal nursing 
research studies which found that of the 44 studies that reported sample sizes at both the start 
and end of the study, 20% experienced 50% attrition (SmithBattle, Lorenz, Reangsing, Palmer, 
& Pitroff, 2018). Numerous authors have explored methods to improve recruitment and 
minimize attrition, including some which were employed in this study (such as phone calls to 
participants, mailing reminders, minimizing study burden, incentive payments), with noted 
varying degrees of success (Aitken, Gallagher, & Madronio, 2003; Treweek et al., 2013). 
However, it does appear that this author’s challenges with recruitment from these particular 
institutions is not unique, as demonstrated by a study by Dr. Weierback, a PhD Neifdelt 





of recruitment, 28 individuals consented to participate in the study, and 20 were 
interviewed…”(p. 46). 
Quantitative Data 
Evaluation of the quantitative data for preliminary trends focused on four specific areas 
of exploration: prevalence data from three different measurement instruments; changes over 
time in depressive symptom dimensions; the influence of CHD and depression on three 
overlapping somatic symptoms; and the influence of pre-identified factors on depressive 
symptom burden. Findings regarding prevalence were similar to prior research findings at 
baseline with a decrease at month two, but remained higher at month three than prevalence 
rates in prior studies (Buckland, Pozehl, & Yates, 2019). The role of screening for depression in 
the CHD population has been debated ever since the American Heart Association recommended 
performing screenings in 2008 (Lichtman et al., 2008), with several authors arguing that it does 
not improve outcomes (Thombs et al., 2013; Ziegelstein, Thombs, Coyne, & de Jonge, 2009) and 
others arguing that it is financially feasible and does improve depression, which has other 
positive ripple effects (Ski et al., 2012; Sowden, Mastromauro, Januzzi, Fricchione, & Huffman, 
2010). The results of this study suggest that perhaps screening in certain CHD sub-populations 
may be beneficial. 
The comparison of instruments in this feasibility study yielded valuable new 
information. The PROMIS Depression 8b, a relatively new instrument that has not yet been used 
extensively in the cardiac population and does not contain somatic symptoms, was compared to 
the BDI-II and PHQ-9 which both contain somatic symptoms. It was expected that the PROMIS 
would yield significantly lower prevalence of depression based on previous findings in other 
instruments that do not contain somatic symptoms (Buckland et al., 2019). However, the 





Some authors have argued that including somatic symptoms on depression screening 
instruments confuses the clinical picture and makes correct diagnosis more difficult (DeVon, 
personal communication, 2014; (Snaith & Zigmond, 1986). Others point to these symptoms as 
indicators of potential worse outcomes in CHD patients (de Miranda Azevedo, Roest, Hoen, & de 
Jonge, 2014) or as a means of deciphering the underlying CHD from depression (McGuire, 
Eastwood, Hays, Macabasco-O'Connell, & Doering, 2014). Given the performance of the PROMIS 
Depression 8b in this study, this instrument may provide measures similar to somatic item-
containing instruments.  
Changes over time in depressive symptom dimensions as defined by Lenz et al. in their 
Theory of Unpleasant Symptoms (timing, severity, symptom distress, and quality – here, somatic 
vs cognitive) showed an interesting trend. Mean scores on the depressive symptom instruments 
(severity) and scores on the Subjective Units of Distress scale (distress) demonstrated a decrease 
between baseline and month 2 but then showed an increase between months 2 and three, 
though the increase in scores were not statistically significant. This pattern was also noted in 
changes in somatic depressive symptom scores but not in cognitive symptom scores. Prior 
studies have found varying patterns of change in women’s symptom severity over time, though 
most appear to improve (Buckland et al., 2019). The fact that overall mean depression scores as 
well as symptom distress scores followed the same pattern as somatic symptom scores supports 
the centrality of somatic symptoms in women’s experience of depressive symptoms in this 
population. 
This study proposed to examine the influence of CHD and depression on three 
overlapping somatic symptoms: sleep, fatigue, and GI symptoms. There was a very strong 
correlation between both depression scores and ACS scores (used as a proxy for CHD in this 





that the items with the highest mean scores on the BDI-II and PHQ-9 in this study were somatic 
symptoms: sleep changes, fatigue & loss of energy, appetite changes, and loss of interest in sex. 
The only cognitive symptom with a similarly high mean score was anhedonia. Changes in 
thinking regarding depression have led some to recommend more focus be placed on individual 
symptoms versus sum scores: individual symptoms may be more reflective of underlying biology 
and may also affect the degree of impairment of the individual (Fried & Nesse, 2015). A recent 
study by Carney et al. (2018) examining residual depressive symptoms in the CHD population 
after treatment with 6-12 sessions of individual cognitive behavior therapy (CBT) found that loss 
of energy (69.1% of participants) and fatigue (55.6% of participants) were the most commonly 
cited residual symptoms. The third most common, and only other symptom to affect >50% of 
participants post-treatment, was anhedonia (51.6% of participants). Thus, the feasibility study 
findings appear to be consistent with other study findings, but they are also concerning since 
these women appear to be experiencing the symptoms that are most resistant to treatment. 
Weaker correlations were found between depression scores and GI symptom scores over time, 
though there was a robust correlation between GI symptom presence at baseline and 
depression screening scores across time.  More consistent correlations were noted between GI 
symptom scores and the corresponding ACS scores across time. The generally weaker 
correlations between GI symptoms and depression screening scores may be a result of the poor 
reliability of the instrument in this study. It may also be a reflection of symptoms on the scale 
not associated with depression, such as lack of taste and nausea. While the ACS symptom 
checklist found statistically significant correlations with the three overlapping somatic 
symptoms (fatigue, sleep changes, and GI symptoms), this may in fact be a reflection of 
measurement redundancy since the ACS symptom checklist contains items related to both 





 The influence of pre-identified factors on depressive symptom burden was also examined in 
this study: specifically, the influence of age, diabetes, a history of depression and/or anxiety, 
attendance at cardiac rehabilitation, ACS symptoms, and employment status. There was a 
strong correlation between age and depressive symptom burden in this study. 
Women whose scores on the depression screening instruments met cutoff criteria had a mean 
age of 46.25, versus a mean age of 69.38 for those who did not.  At age 46, women are more 
likely to still be working, may still have children at home, may be caring for grandchildren and/or 
be caring for aging parents. A significant change in health status may be quite disruptive to 
these women's’ roles and responsibilities, decreasing their ability to provide both tangible and 
emotional support to their families. A recent study looking at perceived stress post MI in young 
and middle-aged women compared to men found that women had higher stress levels initially 
and over the next 12 months compared to men (Xu et al., 2017). Shah et al.’s (2014) study 
examining the association of depression with CHD and adverse cardiac events found a 
correlation between depression and CHD and risk of death in women age ≤ 55. These findings 
suggest that not only are younger women with CHD struggling, but their lives may be at risk if 
they develop clinically significant depression. 
 This feasibility study also found a very strong correlation between depression and a history 
of diabetes. The correlation between diabetes and depression, even without the presence of 
CHD, has been found to be significant (Kanapathy & Bogle, 2019). The combination of diabetes, 
depression, and CHD puts women at even greater risk of poor outcomes than diabetes and 
depression alone (Pan et al., 2011).  Research exploring a possible common root cause for both 
CHD and diabetes has been a topic of interest, leading to studies of genetic overlap (Amare, 
Schubert, Klingler-Hoffmann, Cohen-Woods, & Baune, 2017) as well as development of systems 





experiencing comorbidity with diabetes and CHD will need significant amounts of education, 
close follow-up, and both tangible and emotional support. The importance of exercise in 
improving diabetes, depression, and CHD needs to be clearly conveyed. Cardiac rehabilitation, 
which has been shown to be effective in improving depressive symptoms as well as lowering 
cardiac risk (Rutledge, Redwine, Linke, & Mills, 2013) will be particularly important in this group 
of patients. Approaches such as behavioral activation, which has been delivered as a manualized 
intervention (Ekers, Richards, McMillan, Bland, & Gilbody, 2011; Pasterfield et al., 2014) as well 
as on-line (Spates, Kalata, Ozeki, Stanton, & Peters, 2013) may be a viable option to keep 
patients motivated following cardiac rehabilitation. 
 Current depressive symptoms were strongly associated with a history of anxiety in this 
study. Prior research has found comorbidity of depression and anxiety to be common, 
particularly in women, and this appears to be true in the CHD population as well (Sundel, Stain-
Mahngren, Andersson, Aberg-Wistedt, & Schenck-Gustafsson, 2007; van Montfort, Denollet, 
Vermunt, Widdershoven, & Kupper, 2017). Prior studies have also shown a history of anxiety to 
be a significant predictor of subsequent depression in CHD patients (Murphy et al., 2014; 
Schrader, Cheok, Hordacre, & Marker, 2006). Interestingly, this feasibility study demonstrated a 
stronger association between a history of anxiety and current depression than a history of 
depression and current depression (though both demonstrated significance at more than one 
timepoint). This may be a reflection of small participant numbers, and more participants with a 
history of anxiety than depression in this study. A recent scoping review of risk factors for 
depression in individuals with CHD found a history of depression to be a stronger predictor of 
subsequent depression than a history of anxiety (Greenman et al., 2018).  
This study found a strong correlation between depressive symptom scores and 





cardiac rehabilitation less than those who had lower scores. This is consistent with prior 
literature showing that women with greater depressive symptom burden are less likely to 
complete cardiac rehabilitation (Sanderson & Bittner, 2005). In a systematic review of studies 
examining the effects of exercise on depression in CHD patients, exercise has demonstrated 
improvement in depression both in the short and long term in those with increased levels of 
depression (Verschueren et al., 2018). Even in women with microvascular disease, a relatively 
recently discovered and still poorly understood condition more often affecting women than 
men, exercise appears to improve quality of life (Szot, Zając, Kostkiewicz, Owoc, & Bojar, 2015).  
There was a strong correlation between depressive symptom scores and ACS scores in 
this study. ACS symptoms, particularly angina, have been associated with increased depressive 
symptom burden in CHD patients in general and women in particular (Jespersen, Abildstrom, 
Hvelplund, & Prescott, 2013; Sundel et al., 2007; Trivedi et al., 2015). A meta-analysis of studies 
across 31 countries demonstrated that women were more likely to experience angina than men 
(Hemingway et al., 2008). Angina appears to be a more significant problem in those who do not 
have “classic” coronary artery disease which is amenable to intervention such as stenting or 
bypass (Jespersen et al., 2013). Because non-obstructive disease is more common in women 
(Pasupathy, Tavella, & Beltrame, 2016), women appear to be at higher risk of developing 
associated depression. Evidence-based therapies for people who experience cardiac ischemia 
without obstruction (INOCA) are just evolving, and the Cardiovascular Disease in Women 
Committee of the American College of Cardiology have developed an agenda to advance this 
area (Bairey Merz, Pepine, Walsh, & Fleg, 2017) 
No significant correlation was noted between depression and employment status in this 
study. This was an unexpected finding. A recent meta-analysis of observational studies 





for developing depression whereas being employed was protective (Mei-zhen et al., 2019). This 
lack of correlation may be related to the way this question was posed in the survey. Women 
were asked if they had held a steady job in the past 6 months – “yes” or “no/retired”. Because 
those who are not working by choice (retired) may feel quite different from those who are 
involuntarily unemployed, this answer choice may have masked the negative feelings of those 
who were unemployed but desired to work. A future study will need to change wording to 
ensure that responses separate those who are unemployed by choice from those who are not. 
Qualitative Data 
Unlike focus groups, individual interviews, or qualitative questions at the end of 
quantitative surveys, the use of “purely qualitative” survey as a means of collecting qualitative 
data has not been widely used in health care research (Terry & Braun, 2017, p. 17). Little 
guidance from the literature exists for qualitative survey as a means of data collection. In his 
paper on qualitative survey research, Jansen (2010) describes qualitative survey as “the study of 
diversity (not distribution) in a population” (section 2.0, para. 6). According to Jansen (2010) 
qualitative surveys may use either open-ended or pre-structured questions, and that “the 
qualitative-versus-quantitative nature of data is established in the analysis. It is not inherent 
ontology but analysis which determines whether a study is qualitative or quantitative” (section 
2.1, para. 3). Terry and Braun (2017) view qualitative surveys as being suitable to answer 
questions about people’s experiences, practices, views and perspectives. 
Due to concerns about influencing participants because of the longitudinal nature of the 
study as well as the fact that objective data was also being collected at the same time, a method 
which would generate rich data while minimizing contact with study participants was sought. 
Qualitative survey was felt to be a good choice. However, given the longitudinal nature of this 





study would have benefitted from iteratively revising the survey based on the previous survey 
content. Participation in the qualitative surveys in this study was poor. This may be due in part 
to the fact that the qualitative survey was optional in this study and the PI did not stress the 
importance of carrying through with the surveys if participants stated they were interested. 
More practical issues also arose, such as participants not being sure what to physically write 
“on” (a personal diary, ruled notebook paper, etc). Despite offering to have participants answer 
the survey in a word processing program and submit responses electronically, only one 
participant chose to use this method. While interesting and useful data was generated in this 
study, the use of qualitative survey as a means of qualitative data collection would need to be 
significantly improved if it were to be used in a future study and would certainly require a small 
pilot study of its own to ensure adequacy of adjustments. 
Strengths and Limitations 
One of the strengths of this study is recruitment of women from three different types of 
institutions - a large urban public hospital, a large urban private hospital, and a smaller regional 
hospital – providing a wide representation of women despite its small size. This study adds 
needed granular details regarding depressive experiences of women with CHD over time to the 
existing literature. It also provides a preliminary assessment of one of the PROMIS Depression 
short form tools in the CHD population. The mixed methods design produced qualitative data 
showing that women with higher depressive symptom scores report different experiences post 
cardiac event than women who experience fewer depressive symptoms.  
There were several limitations to this study. The small sample size limited the statistical 
analyses that were possible to perform, particularly estimating an effect size for influence of 
CHD and depression on three common overlapping somatic symptoms. Poor uptake of the 





not assess who was and was not on antidepressant medications and/or undergoing counseling 
for depression at the start and during the study. This may have influenced outcomes. The 
grouping of retired and unemployed women together may be responsible for the lack of 
correlation between depression scores and employment, as those who are unemployed by 
choice may feel very differently about their status than those who are not working because they 
are not able. Finally, the poor reliability of the GI symptom instrument is likely responsible for 
the lack of correlation between GI somatic symptom and depression scores.  Alternative 
measures should be considered in future studies. 
Conclusions and Future Recommendations 
These study findings suggest that the PROMIS may be an excellent choice of instrument 
for those who have significant concerns about measuring somatic symptoms and wish to choose 
an instrument that does not contain somatic items since it demonstrated prevalence similar to 
BDI-II. Performance of the PROMIS Depression 8b in the female CHD patient population would 
benefit from further examination in a larger sample. A dedicated study examining ROC curves 
for sensitivity and specificity of the PROMIS Depression 8b versus other measures containing 
somatic symptoms compared to diagnostic interview findings in this population would also be 
beneficial.   
The finding that overall mean depression scores as well as distress scores trended in the 
same direction as the somatic symptom scores supports the centrality of somatic symptoms in 
women’s experience of depressive symptoms but also suggest that women in particular may be 
at increased risk of having residual depressive symptoms, even if they receive appropriate 
treatment (Carney et al., 2018). A multi-modality approach may be required to alleviate these 
somatic symptoms given the difficulty in treating them to remission with CBT alone (Carney, 





women in this population is important since depressive symptoms are associated with worse 
outcomes (Lichtman et al., 2014). The role of somatic depressive symptoms in this population 
needs to continue to be explored.  Analysis of individual depressive symptoms to elucidate 
further which specific symptoms are most often reported, by whom, and which remain 
unresolved following treatment will aid in development of approaches which can target these 
symptoms, preventing persistent depression and potential worse outcomes. 
This and other prior research have demonstrated that younger women experience much 
more depression than older women. Why this particular group of women is at elevated risk 
remains a question. Risk factors need to be elucidated to determine which are amenable to 
intervention. Women with comorbid diabetes are another group who clearly demonstrated 
more depression in this study than women who do not have diabetes. The co-occurrence of 
depression in multi-morbid individuals is not a unique finding to this study.  Because diabetes, 
depression, and CHD all respond positively to physical activity, studies comparing different 
strategies already shown to promote physical activity in this population should be undertaken. 
The strong correlation between baseline depressive symptom scores and attendance at 
cardiac rehabilitation has implications for post-discharge care of these cardiac patients. This 
relationship suggests that women who are depressed early on after their cardiac event may not 
be as attuned to care needs later on in the recovery period. The importance of attending cardiac 
rehabilitation needs to be emphasized to women who screen positive for elevated depressive 
symptoms either during their hospital stay or at their initial follow-up appointment since these 
women appear to be at significant risk of non-attendance.  
Finally, dedicated efforts to include women and men in equal numbers in CHD studies 





participants need to be priorities in CHD research moving forward if we are to improve 
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APPENDIX A: Longitudinal studies of depressive symptoms in women with CHD 
 
Author & date Study purpose Study design Sample Depression 
scale/other 
Results (% or average score  SD) 
                                                          
1 Cardiac rehabilitation 
2 Percutaneous coronary intervention 
3 Hospital Anxiety & Depression Scale 
1.  Barth et 
al., 2009 
Examine whether 
women & men 
benefit equally from 













• Baseline: 2-4 weeks post 
acute event 













PCI2, or heart 
surgery 
• Anxiety & 
Depression: 
German 
version of  
HADS3 
Baseline prevalence of HADS-D7: 15% (no separation 
by gender) 
• Baseline depression (difference: p=0.29) 
o Women: 3.6  3.0 
o Men: 3.9  3.5 
• Depressive symptoms post CR (p=0.626) 
o Women: 3.1 3.2 
o Men: 3.1  3.1 
o  
No age difference between men & women in this study 
(unusual) 
 
a.  Bogg et 
al., 2000 
Assess the influence 
of gender on 
outcomes after a 
cardiac episode.  
• Prospective longitudinal 
cohort study 
Time-points: 
• Baseline: 3-4 days post MI 
• Time 2: 1 month post MI 
• Time 3: 3 months post MI 








within 4 days 
• Depression: 
HADS 
Baseline depression (nonsignificant) 
• Women: 4.7  3.4 
• Men: 4.0  3.2 
1 month post MI (p0.01; T=2.68) 
• Women: 5.6  3.1 
• Men: 4.4  3.9 





                                                          
4 Beck Depression Inventory - ll 
of admit, 
age<75. 
• Women: 5.9  3.4 
• Men: 3.9  3.1 
6 months (nonsignificant) 
• Women: 4.7  3.0 
• Men: 3.9  3.5 
Depression was a major predictor of physical quality of 
life.  
2.  Brink et 
al., 2005 
Detect changes in 
HRQOL over time, 
and predict HRQOL 
at 1 year based on 
measures at 1 week 
& 5 months post 1st-
time MI. 
• Longitudinal descriptive 
study 
Time-points: 
• Baseline: 1 week post MI 
• Time 2: 5 months 








Baseline depression (estimated, based on graphic) 
• Women: 2.4 
• Men: 2.7 
5 months 
• Women: 4.1  3.2 
• Men: 3.8  3.8 
12 months 
• Women: 2.8  2.8 
• Men: 3.4  3.5 
Statistically significant decrease in women between 5 
months and 1 year (p0.01) 
13% of all respondents scored possible or likely 
depression 1 year after MI. 







symptoms & sex on 
completion rates in 
CR and, in CR 
completers,  
examine clinical 
• Retrospective cohort 
analysis 
Time-points: 
• Baseline: 4-6 weeks post 
hospital discharge 















of CR: >7 
weeks’ 
Baseline BDI-ll 14: 
• Women: 31% 
• Men: 14.5% 
53 people/29 women (54.7%) did not complete CR. 
• 29 (54.7%) CR non-completers had BDI-II 14 at 
baseline. 





                                                          
5 Coronary artery bypass graft 
6 Diagnostic Interview & Structured Hamilton 





reduction after CR vs. pts with baseline BDI-ll<14 
• 14: pre-CR=20.6; post-CR=10.4 
• 14: pre-CR=5.8; post-CR=3.5 
No statistically significant difference between amount 
of change on BDI-II after CR between men & women 








somatic & affective 
symptoms 
• Longitudinal descriptive 
study 
Time-points: 
• Baseline measure: inpatient 
• Time 2: 2-4 weeks post 
discharge 
• Time 3: 6 months  
75 women 
• 55 retained 










Baseline Depressed: 36% 
Time 2 Depressed: 16.3% 
Time 3 Depressed: 12.7% 
• Depressed women were younger (57 vs 64.2) 
• More of the depressed women had hx of depression 
vs those with no hx of depression (40.7% vs 18.8%) 
• Depressed women consistently had higher rates of 
fatigue, anhedonia, & dysphoria vs non-depressed 
women over the 6-month period. 
5.  Duits et 
al., 1998 
Examine variations 
over time in anxiety 
& depression in pts 
undergoing CABG 
• Longitudinal descriptive 
study 
Time-points: 
• Time 1: 2 weeks pre-op 
• Time 2: 1 day pre-op 
• Time 3: 7 days post-op 













• Women: 7.5  4.7 
• Men: 4.7  3.7 
Time 3 
• Women: 5.4  3.4 
• Men: 4.9  3.6 
Time 4 
• Women: 4.9  4.0 
• Men: 3.4  3.5 
Both significant time effect, & significant time modified 
by gender effects were noted. 
6.  Grace et 
la., 2005 
Examine the 
prevalence & course 












                                                          
7 Myocardial infarction 
8 Unstable angina 
of depressive 
symptoms x 1 yr 
after ACS, & the 
effect of CR on this 
trajectory 
Time-points: 
• Baseline: inpatient 
• Time 2: 6 months 









6 months: 25.2% 
12 months: 21.7%  
• Those with higher BDI scores at 6 months attended 
significantly fewer CR sessions than those with lower 
BDI scores (p=0.02). 
• Depressive symptoms improved for all, regardless of 
CR participation. 
• Younger participants were more depressed 






who participated in 
CR with those who 
did not. 





• Baseline (inpatient) 







ACS, PCI, or 
CABG. 




51 women (45.1%) participated in CR 
Baseline: (nonsignificant difference between groups) 
• CR: 4.6  3.5 
• Non-CR: 5.0  2.8 
18 months: 
• CR: 4.3  3.7 
• Non-CR: 4.1  3.3 
Women who did not participate in CR by 18 months 




Examine the impact 
of angina and 
cardiac hx on 
depression and 
HRQOL in CHD pts. 
• Prospective longitudinal 
study 
Time-points: 
• Baseline: 45 days post-
cardiac event 
















• Women no prior CHD: 1.45  0.17 
• Men no prior CHD: 1.39  0.14 
• Women prior CHD: 1.51  0.11 
• Men prior CHD: 1.45  0.13 
6 months 
• Women no prior CHD: 1.39  0.17 
• Men no prior CHD: 1.34  0.13 
• Women prior CHD: 1.47  0.11 
• Men prior CHD: 1.44  0.13 





                                                          





baseline, but predictive at 6 months. 
Women had higher depression levels than men at 
baseline. 
Depression scores in pts with CHD hx remained stable, 
whereas pts with no cardiac hx had improvement. 
9.  Gupta et 
al., 2007 
To see if benefits 
from CR are 
maintained at 1 yr, 
& if there are any 
gender-specific 
differences. 
• Longitudinal descriptive 
study 
Time-points: 
• Baseline: CR entry 
• Time 2: 6 months 







244 at 1-yr 
• Women: 68 
(28%) 








• Women: 9.7 
• Men: 9.29 
CR completion 
• Women: 6.9 
• Men: 5.4 
1 year 
• Women: 7.3 
• Men: 5.81 
Both men & women showed significant improvement in 
depressive symptoms… 
• between baseline & end of CR, and 
• between baseline & 1 yr 







affect, & depression 
over a 2-year period 





• Longitudinal descriptive 
study 
Time-points: 
• Baseline: inpatient 
• Time 2: 6 months 
• Time 3: 12 months 















• Women: 27.9% 
• Men: 18.7% 
6 months 
• Women: 20.6% 
• Men: 14.5% 
12 months 
• Women: 19.2% 















• Women: 19.2% 
• Men: 13.3% 
Women demonstrated more autonomic anxiety & 
depression than men across entire study 
Exercise did not mediate any gender/affective relation-
ships 
No moderation by gender 







cardiac pts in CR. 




• Baseline: Pre-CR 














• Women: 36% 
• Men: 22% 
Baseline (mean score) 
• Women: 8.73  7.68 
• Men: 6.44  6.2 
Post-CR 
• Women: 5.44  5.76 
• Men: 4.21  4.76 
Pts had significantly higher BDI scores prior to CR 
compared to after. 
Women showed a larger reduction in BDI scores after 
CR than men. 
Pts who did not complete CR had higher BDI scores 
than those who did complete CR. 
12.  Lavie & 
Milani, 
1995 
Assess 1) gender 
differences post 





QOL & 2) 
improvement 
in these after CR. 
• Retrospective data review 
Time-points: 
• Baseline: pre-CR 
























• Women: 3  4 
• Men: 3  5 
Post-CR 
• Women: 3  5 
• Men: 2  4 
Depressive symptoms were significantly reduced in 



















CAD, & assessed the 
modulatory effects 
of CR & exercise 
training programs 
• Prospective longitudinal 
descriptive study 
Time-points: 
• Baseline: pre-CR (4-5 wks 
post cardiac event) 
• Time 2: 1 week after CR 
completion. 




















Baseline depression ≥7: 22.5% 
Post-CR depression ≥7: 12% 
 
• Study supported frequency of depression in women 
with CAD. 
• Improvement in depressive symptoms following CR. 
• Baseline characteristics failed to identify the 
depressed women who improved following CR 






anxiety on patient 
completion of 
structured CR. 
• Longitudinal, descriptive, 
retrospective chart review 
Time-points: 
• Baseline: start of CR 



















• Women: 10.9  8.4 
• Men: 8.3  7.3 
Baseline (BDI-II 10 or BAI15) 
• Women: 17.4  6.6 
• Men: 20.0  8.1 
Post-CR (BDI-II 10 or BAI15 at baseline) 
• Women: 10.5  6.2 
• Men: 12.9  9.4 
Women had overall higher BDI-II scores than men at 
baseline. 
No statistically significant gender differences in 
outcomes post-program. 
Significant differences in baseline BDI-II between 







Younger, female patients had higher dropout rates. 





symptoms as they 
relate to HRQOL 
post MI. 
• Longitudinal, prospective 
cohort study 
Time-points: 
• Baseline: inpatient 















Baseline BDI-II 10: 
• Women: 40.3% 
• Men: 32.7% 
1-yr BDI-II10: 
• Women: 40.4% 
• Men: 31.9% 
No significant differences in depression scores between 
men & women at baseline. 
Women had worsening mean BDI-II scores over the 1st 
year post-AMI. 
Women more likely to have DM, HTN 
16. q Phillips 
Bute et 
al., 2003 
Examine QOL & 
cognitive outcomes 
after CABG in men 
& women, carefully 
adjusting for 
baseline differences 
& known pre-op risk 
factors for poor 
outcomes. 
• Prospective longitudinal 
observational study 
Time-points: 
• Baseline: inpatient 
• Time 2: 1 year 
343 pts at 
baseline 
 











• Women: 16.95  11.06 
• Men: 11.10  9.39 
12 months 
• Women: 13.91  9.58 
• Men: 9.02  8.48 
Women’s scores significantly higher than men’s at both 
time points. 
Women’s recovery not significantly different from 
men’s - differences could be attributed to pre-op 
differences in depression levels. 









w. CR completers; 
describe outcomes 
• Longitudinal descriptive 
study 
Time-points: 
• Baseline: pre-CR 
• Time 1: post-CR 
228 women: 
• 121 CR 
completers 







Baseline BDI-II≥14: 31% 
After CR: 
• 67% of women had improved BDI-II scores 
• 6% had no change 
• 27% had higher scores compared to baseline 
_________________________ 
• 50% of CR non-completers had a BDI-II score >14 vs 










• CR non-completers were younger, more obese than 
completers. 
Women who had higher scores after CR than at 
baseline still had mean score <14. 
18.  Shin et al., 
2010 
Explore gender 
differences in the hx 
of depression, 
depressive 
symptoms, & use of 
anti-depressants in 
pts hospitalized for 
ACS & 1-month 
post-discharge. 
• Prospective longitudinal 
design 
Time-points: 
• Baseline: inpatient 




















• Women: 38.8%  
• men=29.4% 
1 month: 
• women: 26.3% 
• men=25% 
Hx depression: 
• Women: 34.7% 
• Men: 17.6% 
Taking antidepressants (baseline) 
• Women: 38.8% 
• Men: 15.7% 
___________________ 
No statistical difference in severity of depressive 
symptoms by gender at either time-point. 
No improvement from baseline to 1 month 
More women than men had hx of depression 




specific changes in 
well-being in older 
people with CHD vs 
those without over 
a 6-year period. 
• retrospective longitudinal 
case-control study 
Time-points: 
• Baseline: within 2 yrs of a 
CHD event 
• Time 2: 1 year after baseline 














Prevalence of depressive “caseness” was higher in CHD 
vs healthy group 
• For women with CHD, presence of depressive 
caseness was constant between baseline and 2-yr f/u, 
but 8% lower at 4-yr f/u compared to baseline. 
• At baseline & 2-yr f/u, women had 13% higher 
probability of depressive caseness vs men. 
o This decreased to 5% at 4-yr f/u.  
Among CHD pts, depressive caseness was constant over 











































APPENDIX F: Institutional Review Board Protocol Change Approvals UNMC 
































































































































The purpose of this journal is to give the researcher (me) a more detailed way to 
understand what you are feeling – particularly feelings of depression. People experience 
symptoms of depression in many different ways. It may not be clear to you if what you 
are feeling is depression or anxiety or anger or even symptoms of your heart disease. 
That’s OK. Please include anything that you think will help me understand what you are 
feeling. 
Please spend at least 15 minutes a day, at least 3 out of the next 7 days, writing in 
this journal. The following list contains examples of the kinds of things I hope you will 
comment on/write about. 
 
1. The timing of your depressive symptoms 
• Have you noticed that your emotions/mood changes with the time of day, or 
during certain parts of the week? 
• Do your emotions change (improve or get worse) with certain activities, and if 
so what are those activities? 
• Have you noticed a “trend” in your mood overall – either improvement or 
decline? 
2. The severity of your depressive symptoms 
• If you have noticed a certain feeling (for example, fatigue or trouble 
concentrating), has it been mild/minor or has it been rather 
significant/severe? 
• Have you noticed if anything in particular seems to change the severity of 
your symptoms (either for better or worse)? 
3. The distress caused by your depressive symptoms 
• How bothered or distressed by your mood/feelings have you been? 
4. The quality of your depressive symptoms 
• What “cognitive” (emotional) symptoms have you been experiencing (such as 
feeling down or not being interested in doing anything)? 
• What “somatic” (physical) symptoms have you been experiencing (such as 
fatigue or poor appetite) that you think are related to your feelings rather than 










The purpose of this journal is to give the researcher (me) a more detailed way to 
understand what you are feeling, particularly in regards to your mood/emotions. People 
experience many different feelings after they are diagnosed with a chronic illness such 
as coronary heart disease. It may not be clear to you if what you are feeling is 
depression or anxiety or anger or even symptoms of your heart disease (as things like 
fatigue and poor sleep can be mood-related as well as disease-related). That’s OK. 
Please include anything that you think will help me understand what you are feeling. 
Please spend at least 15 minutes a day, at least 3 out of the next 7 days, writing in 
this journal. The following list contains examples of the kinds of things I hope you will 
comment on/write about. 
 
5. The timing of your feelings/mood changes 
• Have you noticed that your emotions/mood changes with the time of day, or 
during certain parts of the week? 
• Does your mood change (improve or get worse) with certain activities, and if 
so what are those activities? 
• Have you noticed a “trend” in your mood overall – either improvement or 
decline? 
6. The “severity” of your feelings/mood 
• If you have noticed a certain mood, has it been mild/minor or has it been 
rather significant/severe? 
• Have you noticed if anything in particular seems to change the severity of 
your feelings (either for better or worse)? 
7. The distress caused by your feelings 
• How bothered or distressed by your mood/feelings have you been? 
8. The quality of your feelings/mood 
• What “cognitive” (thinking/brain) symptoms have you been experiencing 
(such as feeling down or not being interested in doing anything)? 
• What “somatic” (physical/body) symptoms have you been experiencing (such 
as fatigue or poor appetite) that you think are related to your feelings rather 
than your heart disease? 
 
